{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import wikidataintegrator as wdi"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "source_url = 'http://ec.europa.eu/health/documents/community-register/html/alforphreg.htm'\n",
    "scrap_res = pd.read_html(source_url, attrs={'id': 'wmtable'}, header=0, index_col=None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Product</th>\n",
       "      <th>EU Designation</th>\n",
       "      <th>Designated Orphan Indication</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Designation date</th>\n",
       "      <th>TradenameEU Centralised NrImplemented on</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...</td>\n",
       "      <td>EU/3/10/767</td>\n",
       "      <td>Treatment of post-essential thrombocythaemia m...</td>\n",
       "      <td>CTI Life Sciences Ltd</td>\n",
       "      <td>25/08/2010</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...</td>\n",
       "      <td>EU/3/10/768</td>\n",
       "      <td>Treatment of primary myelofibrosis</td>\n",
       "      <td>CTI Life Sciences Ltd</td>\n",
       "      <td>25/08/2010</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...</td>\n",
       "      <td>EU/3/10/769</td>\n",
       "      <td>Treatment of post-polycythaemia vera myelofibr...</td>\n",
       "      <td>CTI Life Sciences Ltd</td>\n",
       "      <td>25/08/2010</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>11-(4-Dimethylamino-3-hydroxy-6-methyl-tetrahy...</td>\n",
       "      <td>EU/3/14/1239</td>\n",
       "      <td>Treatment of cystic fibrosis</td>\n",
       "      <td>Synovo GmbH</td>\n",
       "      <td>19/02/2014</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-{1-[(2...</td>\n",
       "      <td>EU/3/14/1281</td>\n",
       "      <td>Treatment of cystic fibrosis</td>\n",
       "      <td>Vertex Pharmaceuticals (Europe) Limited</td>\n",
       "      <td>04/07/2014</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             Product EU Designation  \\\n",
       "0  11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...    EU/3/10/767   \n",
       "1  11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...    EU/3/10/768   \n",
       "2  11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...    EU/3/10/769   \n",
       "3  11-(4-Dimethylamino-3-hydroxy-6-methyl-tetrahy...   EU/3/14/1239   \n",
       "4  1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-{1-[(2...   EU/3/14/1281   \n",
       "\n",
       "                        Designated Orphan Indication  \\\n",
       "0  Treatment of post-essential thrombocythaemia m...   \n",
       "1                 Treatment of primary myelofibrosis   \n",
       "2  Treatment of post-polycythaemia vera myelofibr...   \n",
       "3                       Treatment of cystic fibrosis   \n",
       "4                       Treatment of cystic fibrosis   \n",
       "\n",
       "                                   Sponsor Designation date  \\\n",
       "0                    CTI Life Sciences Ltd       25/08/2010   \n",
       "1                    CTI Life Sciences Ltd       25/08/2010   \n",
       "2                    CTI Life Sciences Ltd       25/08/2010   \n",
       "3                              Synovo GmbH       19/02/2014   \n",
       "4  Vertex Pharmaceuticals (Europe) Limited       04/07/2014   \n",
       "\n",
       "  TradenameEU Centralised NrImplemented on  \n",
       "0                                      NaN  \n",
       "1                                      NaN  \n",
       "2                                      NaN  \n",
       "3                                      NaN  \n",
       "4                                      NaN  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "eu_orphan_drugs = scrap_res[0] # get first table in table list\n",
    "eu_orphan_drugs = eu_orphan_drugs.loc[eu_orphan_drugs['Product'].notnull(), :]\n",
    "eu_orphan_drugs.reset_index(inplace=True)\n",
    "eu_orphan_drugs = eu_orphan_drugs.drop('index', 1)\n",
    "eu_orphan_drugs.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Product                                     1433\n",
       "EU Designation                              1433\n",
       "Designated Orphan Indication                1433\n",
       "Sponsor                                     1433\n",
       "Designation date                            1433\n",
       "TradenameEU Centralised NrImplemented on     113\n",
       "inchi_key                                    196\n",
       "dtype: int64"
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "eu_orphan_drugs.count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "# use OPSIN to convert IUPAC names to InChI keys https://bitbucket.org/dan2097/opsin/\n",
    "\n",
    "with open('input.txt', 'w') as f:\n",
    "    for x in eu_orphan_drugs['Product'].values:\n",
    "        f.write(x + '\\n')\n",
    "        \n",
    "    f.close()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "3 COTOGBTXXUSZQC-UHFFFAOYSA-N\n",
      "4 MJUVRTYWUMPBTR-MRXNPFEDSA-N\n",
      "6 PVCULFYROUOVGJ-UHFFFAOYSA-N\n",
      "7 XXMDDBVNWRWNCW-UHFFFAOYSA-N\n",
      "8 FVJCUZCRPIMVLB-UHFFFAOYSA-N\n",
      "9 XLFKECRRMPOAQS-UHFFFAOYSA-N\n",
      "10 DKGJFKPIUSHDIT-UHFFFAOYSA-L\n",
      "12 XYFPWWZEPKGCCK-GOSISDBHSA-N\n",
      "19 OQDQIFQRNZIEEJ-UHFFFAOYSA-N\n",
      "20 OQDQIFQRNZIEEJ-UHFFFAOYSA-N\n",
      "22 DJSFYNINGIMKAG-FQJQBBMWSA-N\n",
      "23 ZYTXTXAMMDTYDQ-DGEXFFLYSA-N\n",
      "24 LOLPPWBBNUVNQZ-UHFFFAOYSA-N\n",
      "26 PJOSHEDKRPRCAE-QHKWOANTSA-N\n",
      "27 UGJWRPJDTDGERK-UHFFFAOYSA-N\n",
      "31 PGVAKHBXGXBOSB-WINKWTMZSA-N\n",
      "34 SUFPWYYDCOKDLL-UHFFFAOYSA-N\n",
      "35 SUFPWYYDCOKDLL-UHFFFAOYSA-N\n",
      "36 MBOMYENWWXQSNW-AWEZNQCLSA-N\n",
      "37 WEXITTWZMLUGNU-UHFFFAOYSA-N\n",
      "38 RGYQPQARIQKJKH-UHFFFAOYSA-N\n",
      "39 RGYQPQARIQKJKH-UHFFFAOYSA-N\n",
      "40 OOPXYEYPPHJHSE-UHFFFAOYSA-M\n",
      "41 OOPXYEYPPHJHSE-UHFFFAOYSA-M\n",
      "43 AVSMSXHPIYIKIJ-UHFFFAOYSA-N\n",
      "45 QGRQOKJRPFFPKH-HADUGAHKSA-N\n",
      "46 AUFUWRKPQLGTGF-FMKGYKFTSA-N\n",
      "47 AVSAEIJRBBJXNR-UHFFFAOYSA-N\n",
      "48 SOJDTNUCCXWTMG-UHFFFAOYSA-N\n",
      "49 XRPSUWYWZUQALB-UHFFFAOYSA-N\n",
      "50 BKWJAKQVGHWELA-UHFFFAOYSA-N\n",
      "51 MYIFLDFUXIHOCJ-UHFFFAOYSA-N\n",
      "52 QSPOQCXMGPDIHI-UHFFFAOYSA-N\n",
      "55 GDHFOVCRYCPOTK-UHFFFAOYSA-N\n",
      "56 RWWYLEGWBNMMLJ-YSOARWBDSA-N\n",
      "57 FWCVZAQENIZVMY-UHFFFAOYSA-N\n",
      "58 BGBNULCRKBVAKL-UHFFFAOYSA-N\n",
      "59 JBSOOFITVPOOSY-KTKRTIGZSA-N\n",
      "62 HVXBOLULGPECHP-WAYWQWQTSA-N\n",
      "63 BGBNULCRKBVAKL-UHFFFAOYSA-N\n",
      "64 URUBZXVIOILFLM-UHFFFAOYSA-N\n",
      "73 XULSCZPZVQIMFM-IPZQJPLYSA-N\n",
      "74 XULSCZPZVQIMFM-IPZQJPLYSA-N\n",
      "75 XULSCZPZVQIMFM-IPZQJPLYSA-N\n",
      "77 VNDUHYWEWRRBFJ-UHFFFAOYSA-N\n",
      "78 TUWMKPVJGGWGNL-UHFFFAOYSA-N\n",
      "82 KAICRBBQCRKMPO-UHFFFAOYSA-N\n",
      "85 BVJRNKXVSYLNFD-UHFFFAOYSA-N\n",
      "87 UFSKUSARDNFIRC-UHFFFAOYSA-N\n",
      "88 WAAXKNFGOFTGLP-UHFFFAOYSA-N\n",
      "90 CNSJWSLXKSJQFE-UHFFFAOYSA-M\n",
      "91 CNSJWSLXKSJQFE-UHFFFAOYSA-M\n",
      "92 HWSLMIXAPNOWGU-AWEZNQCLSA-N\n",
      "93 YFHRCLAKZBDRHN-MRXNPFEDSA-N\n",
      "94 YFHRCLAKZBDRHN-MRXNPFEDSA-N\n",
      "95 ACNPUCQQZDAPJH-FMOMHUKBSA-N\n",
      "96 ACNPUCQQZDAPJH-FMOMHUKBSA-N\n",
      "97 PZNQZSRPDOEBMS-GBVUCJOHSA-N\n",
      "98 PZNQZSRPDOEBMS-WPUCPVGPSA-N\n",
      "99 GERJIEKMNDGSCS-DQEYMECFSA-N\n",
      "100 UZOSBNQFZUJWFP-UHFFFAOYSA-N\n",
      "101 UZOSBNQFZUJWFP-UHFFFAOYSA-N\n",
      "102 WRFHGDPIDHPWIQ-UHFFFAOYSA-N\n",
      "103 ISXCNDQRTAJCDE-VOTSOKGWSA-N\n",
      "104 TVTXCJFHQKSQQM-LJQIRTBHSA-N\n",
      "106 LQBVNQSMGBZMKD-UHFFFAOYSA-N\n",
      "107 TYORCOLIIIUMSE-UHFFFAOYSA-N\n",
      "109 MBMBGCFOFBJSGT-UHFFFAOYSA-N\n",
      "110 IBGLGMOPHJQDJB-IHRRRGAJSA-N\n",
      "111 HOAHIHGOMCBTFW-CCJJFVKCSA-N\n",
      "112 JRFYJULGAGLHHN-YMNIQAILSA-O\n",
      "115 HFGHRUCCKVYFKL-UHFFFAOYSA-N\n",
      "117 POMVPJBWDDJCMP-RUKDTIIFSA-M\n",
      "118 POMVPJBWDDJCMP-RUKDTIIFSA-M\n",
      "119 POMVPJBWDDJCMP-RUKDTIIFSA-M\n",
      "120 POMVPJBWDDJCMP-RUKDTIIFSA-M\n",
      "124 SRIYKPCSVUEGET-UHFFFAOYSA-N\n",
      "125 SRIYKPCSVUEGET-UHFFFAOYSA-N\n",
      "126 SBHOQYCDAHAMDW-UHFFFAOYSA-N\n",
      "128 CJLUYLRKLUYCEK-UHFFFAOYSA-N\n",
      "130 VSRSUNAZJQGYCB-UHFFFAOYSA-N\n",
      "132 IJDQETGUEUJVTB-UHFFFAOYSA-N\n",
      "133 ZGXJTSGNIOSYLO-UHFFFAOYSA-N\n",
      "134 ZLHFONARZHCSET-UHFFFAOYSA-N\n",
      "135 OQCWNHHZPYJHQR-UHFFFAOYSA-N\n",
      "137 KSGCNXAZROJSNW-UHFFFAOYSA-N\n",
      "138 ZSHXDGCRHXONEP-UHFFFAOYSA-N\n",
      "142 LSXUTRRVVSPWDZ-MKKUMYSQSA-N\n",
      "148 LZJRNLRASBVRRX-ZDUSSCGKSA-N\n",
      "149 FUZYTVDVLBBXDL-UHFFFAOYSA-N\n",
      "150 JTQBMTFVGGUDPN-UHFFFAOYSA-N\n",
      "151 RSQGZEAXODVTOL-UHFFFAOYSA-N\n",
      "152 APVQOOKHDZVJEX-LSBIWMFESA-N\n",
      "156 LFYOZCBFOSSLNJ-UHFFFAOYSA-N\n",
      "173 BSYNRYMUTXBXSQ-UHFFFAOYSA-N\n",
      "308 CIWBSHSKHKDKBQ-JLAZNSOCSA-N\n",
      "309 CIWBSHSKHKDKBQ-JLAZNSOCSA-N\n",
      "379 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "400 RCQXSQPPHJPGOF-UHFFFAOYSA-N\n",
      "401 RCQXSQPPHJPGOF-UHFFFAOYSA-N\n",
      "408 PRKOZMYOBGWMTM-UHFFFAOYSA-N\n",
      "439 QNTASHOAVRSLMD-GYKMGIIDSA-N\n",
      "454 YASYEJJMZJALEJ-UHFFFAOYSA-N\n",
      "470 UFULAYFCSOUIOV-UHFFFAOYSA-N\n",
      "471 UFULAYFCSOUIOV-UHFFFAOYSA-N\n",
      "472 NSKJTUFFDRENDM-UHFFFAOYSA-N\n",
      "473 NSKJTUFFDRENDM-UHFFFAOYSA-N\n",
      "475 OGMADIBCHLQMIP-UHFFFAOYSA-N\n",
      "476 OGMADIBCHLQMIP-UHFFFAOYSA-N\n",
      "499 LDCRTTXIJACKKU-ONEGZZNKSA-N\n",
      "500 IAZDPXIOMUYVGZ-UHFFFAOYSA-N\n",
      "522 OHRURASPPZQGQM-GCCNXGTGSA-N\n",
      "523 OHRURASPPZQGQM-GCCNXGTGSA-N\n",
      "524 OBAIYYJAYGMYJU-UVMLGHLYSA-N\n",
      "541 SBHCLVQMTBWHCD-UHFFFAOYSA-N\n",
      "667 PPZMYIBUHIPZOS-UHFFFAOYSA-N\n",
      "748 VSNHCAURESNICA-UHFFFAOYSA-N\n",
      "827 RJFAYQIBOAGBLC-BYPYZUCNSA-N\n",
      "866 HUWUHKIPYXWUPN-YVRVQSMLSA-N\n",
      "867 WXXSNCNJFUAIDG-UHFFFAOYSA-N\n",
      "869 CJYMGANFUNYUNB-UHFFFAOYSA-O\n",
      "870 CJYMGANFUNYUNB-UHFFFAOYSA-O\n",
      "871 CJYMGANFUNYUNB-UHFFFAOYSA-O\n",
      "872 CJYMGANFUNYUNB-UHFFFAOYSA-O\n",
      "915 PURKAOJPTOLRMP-UHFFFAOYSA-N\n",
      "916 JQLBBYLGWHUHRW-KUBAVDMBSA-N\n",
      "918 RQXMKRRBJITKRN-UHFFFAOYSA-N\n",
      "921 HIEXZUXKTABHCP-PPHPATTJSA-N\n",
      "922 WLRWBXFBIJMKHG-DVNXTAPYSA-N\n",
      "923 LRUQKFVDKCLIRO-UHFFFAOYSA-N\n",
      "926 KVMLMFRXRZLEGU-UHFFFAOYSA-N\n",
      "927 HAYYBYPASCDWEQ-UHFFFAOYSA-N\n",
      "928 QQMKTHUGOQDEIL-UHFFFAOYSA-N\n",
      "929 BZJWEAXPNLNVDX-UHFFFAOYSA-N\n",
      "930 FNDDDNOJWPQCBZ-ZDUSSCGKSA-N\n",
      "931 DHYPGRVMIOATAE-UHFFFAOYSA-N\n",
      "932 VOPDXHFYDJAYNS-UHFFFAOYSA-N\n",
      "933 VVQPUTSNIMAJPT-YTMKKKKMSA-N\n",
      "934 MJOAPUNZUDEDFQ-CNHKJKLMSA-N\n",
      "942 ODCKWAPNRBCXHV-UHFFFAOYSA-N\n",
      "944 IPNATXQRPWRHKD-UHFFFAOYSA-N\n",
      "945 IPNATXQRPWRHKD-UHFFFAOYSA-N\n",
      "946 IPNATXQRPWRHKD-UHFFFAOYSA-N\n",
      "966 SNIOPGDIGTZGOP-UHFFFAOYSA-N\n",
      "970 SOCPXYOQNBBUPS-UHFFFAOYSA-N\n",
      "971 SOCPXYOQNBBUPS-UHFFFAOYSA-N\n",
      "975 JUTBAVRYDAKVGQ-UHFFFAOYSA-N\n",
      "992 SLVOKEOPLJCHCQ-SEYXRHQNSA-O\n",
      "997 LRSYFEZBIMVWRY-VWMHFEHESA-N\n",
      "1012 WUBBRNOQWQTFEX-UHFFFAOYSA-N\n",
      "1069 GPEYTRIZYSZRRK-MHZLTWQESA-N\n",
      "1070 YDZYKNJZCVIKPP-VWLOTQADSA-N\n",
      "1071 XDAOLTSRNUSPPH-XMMPIXPASA-N\n",
      "1072 OLDWOVJAXRWCGT-FBHGDYMESA-N\n",
      "1235 QUMWKKVIZAIAHU-LBPRGKRZSA-N\n",
      "1237 ZLHZLMOSPGACSZ-NSHDSACASA-N\n",
      "1238 SJVQHLPISAIATJ-ZDUSSCGKSA-N\n",
      "1239 SJVQHLPISAIATJ-ZDUSSCGKSA-N\n",
      "1243 HVFWCHDZDIRYBZ-MQZJHDQISA-N\n",
      "1244 HVFWCHDZDIRYBZ-MQZJHDQISA-N\n",
      "1255 MDSQOJYHHZBZKA-GBXCKJPGSA-N\n",
      "1277 PXHANKVTFWSDSG-QLOBERJESA-N\n",
      "1278 HYHSBSXUHZOYLX-WDSKDSINSA-N\n",
      "1279 VFXKYDDSDQXKLC-NBTZWHCOSA-M\n",
      "1280 XLHBNJPXFOZFNJ-BYKQGDNKSA-M\n",
      "1281 SVMPQLHYWRTQCX-WKKXCKAJSA-M\n",
      "1284 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1285 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1286 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1287 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1288 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1289 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1290 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1291 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1292 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1293 WXMKPNITSTVMEF-UHFFFAOYSA-M\n",
      "1295 UKLNMMHNWFDKNT-UHFFFAOYSA-M\n",
      "1296 SUKJFIGYRHOWBL-UHFFFAOYSA-N\n",
      "1297 LPXPTNMVRIOKMN-UHFFFAOYSA-M\n",
      "1298 LPXPTNMVRIOKMN-UHFFFAOYSA-M\n",
      "1299 DHHRUYQFEKUZEL-UHFFFAOYSA-M\n",
      "1300 XKOHIWVZKSEQHP-UHFFFAOYSA-N\n",
      "1301 XKOHIWVZKSEQHP-UHFFFAOYSA-N\n",
      "1302 AKHNMLFCWUSKQB-UHFFFAOYSA-L\n",
      "1303 AKHNMLFCWUSKQB-UHFFFAOYSA-L\n",
      "1304 AKHNMLFCWUSKQB-UHFFFAOYSA-L\n",
      "1305 AEQFSUDEHCCHBT-UHFFFAOYSA-M\n",
      "1369 UCINOBZMLCREGM-ISDLZHGDSA-N\n",
      "1370 LUKBXSAWLPMMSZ-OWOJBTEDSA-N\n",
      "1401 NIJJYAXOARWZEE-UHFFFAOYSA-N\n",
      "1402 NIJJYAXOARWZEE-UHFFFAOYSA-N\n",
      "1421 FHNFHKCVQCLJFQ-UHFFFAOYSA-N\n",
      "1422 FHNFHKCVQCLJFQ-UHFFFAOYSA-N\n",
      "1427 DEVSOMFAQLZNKR-RJRFIUFISA-N\n",
      "1428 DEVSOMFAQLZNKR-RJRFIUFISA-N\n",
      "1430 WHMDKBIGKVEYHS-IYEMJOQQSA-L\n"
     ]
    }
   ],
   "source": [
    "with open('output.txt', 'r') as f:\n",
    "    for count, x in enumerate(f.readlines()):\n",
    "        ikey = x.strip()\n",
    "        if ikey:\n",
    "            print(count, ikey)\n",
    "            eu_orphan_drugs.loc[count, 'inchi_key'] = ikey"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Product</th>\n",
       "      <th>EU Designation</th>\n",
       "      <th>Designated Orphan Indication</th>\n",
       "      <th>Sponsor</th>\n",
       "      <th>Designation date</th>\n",
       "      <th>TradenameEU Centralised NrImplemented on</th>\n",
       "      <th>inchi_key</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...</td>\n",
       "      <td>EU/3/10/767</td>\n",
       "      <td>Treatment of post-essential thrombocythaemia m...</td>\n",
       "      <td>CTI Life Sciences Ltd</td>\n",
       "      <td>25/08/2010</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...</td>\n",
       "      <td>EU/3/10/768</td>\n",
       "      <td>Treatment of primary myelofibrosis</td>\n",
       "      <td>CTI Life Sciences Ltd</td>\n",
       "      <td>25/08/2010</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...</td>\n",
       "      <td>EU/3/10/769</td>\n",
       "      <td>Treatment of post-polycythaemia vera myelofibr...</td>\n",
       "      <td>CTI Life Sciences Ltd</td>\n",
       "      <td>25/08/2010</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>11-(4-Dimethylamino-3-hydroxy-6-methyl-tetrahy...</td>\n",
       "      <td>EU/3/14/1239</td>\n",
       "      <td>Treatment of cystic fibrosis</td>\n",
       "      <td>Synovo GmbH</td>\n",
       "      <td>19/02/2014</td>\n",
       "      <td>NaN</td>\n",
       "      <td>COTOGBTXXUSZQC-UHFFFAOYSA-N</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-{1-[(2...</td>\n",
       "      <td>EU/3/14/1281</td>\n",
       "      <td>Treatment of cystic fibrosis</td>\n",
       "      <td>Vertex Pharmaceuticals (Europe) Limited</td>\n",
       "      <td>04/07/2014</td>\n",
       "      <td>NaN</td>\n",
       "      <td>MJUVRTYWUMPBTR-MRXNPFEDSA-N</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                             Product EU Designation  \\\n",
       "0  11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...    EU/3/10/767   \n",
       "1  11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...    EU/3/10/768   \n",
       "2  11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,...    EU/3/10/769   \n",
       "3  11-(4-Dimethylamino-3-hydroxy-6-methyl-tetrahy...   EU/3/14/1239   \n",
       "4  1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-{1-[(2...   EU/3/14/1281   \n",
       "\n",
       "                        Designated Orphan Indication  \\\n",
       "0  Treatment of post-essential thrombocythaemia m...   \n",
       "1                 Treatment of primary myelofibrosis   \n",
       "2  Treatment of post-polycythaemia vera myelofibr...   \n",
       "3                       Treatment of cystic fibrosis   \n",
       "4                       Treatment of cystic fibrosis   \n",
       "\n",
       "                                   Sponsor Designation date  \\\n",
       "0                    CTI Life Sciences Ltd       25/08/2010   \n",
       "1                    CTI Life Sciences Ltd       25/08/2010   \n",
       "2                    CTI Life Sciences Ltd       25/08/2010   \n",
       "3                              Synovo GmbH       19/02/2014   \n",
       "4  Vertex Pharmaceuticals (Europe) Limited       04/07/2014   \n",
       "\n",
       "  TradenameEU Centralised NrImplemented on                    inchi_key  \n",
       "0                                      NaN                          NaN  \n",
       "1                                      NaN                          NaN  \n",
       "2                                      NaN                          NaN  \n",
       "3                                      NaN  COTOGBTXXUSZQC-UHFFFAOYSA-N  \n",
       "4                                      NaN  MJUVRTYWUMPBTR-MRXNPFEDSA-N  "
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "eu_orphan_drugs.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Product                                     1433\n",
       "EU Designation                              1433\n",
       "Designated Orphan Indication                1433\n",
       "Sponsor                                     1433\n",
       "Designation date                            1433\n",
       "TradenameEU Centralised NrImplemented on     113\n",
       "inchi_key                                    196\n",
       "dtype: int64"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "eu_orphan_drugs.count()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Drug to QID map has 274068 entries!\n",
      "11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 0\n",
      "11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1\n",
      "11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)] heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2\n",
      "1,2:5,6-Dianhydrogalactitol 5\n",
      "1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4 d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one 11\n",
      "1-(4-(N-glycylamido)phenyl)-3-trifluoromethyl-5-(phenanthren-2-yl)-pyrazole-hydrochloride 13\n",
      "1-(4-(N-glycylamido)phenyl)-3-trifluoromethyl-5-(phenanthren-2-yl)-pyrazole-hydrochloride 14\n",
      "16-base single-stranded peptide nucleic acid oligonucleotide linked to 7-amino acid peptide 15\n",
      "16-base single-stranded peptide nucleic acid oligonucleotide linked to 7-amino acid peptide 16\n",
      "16-base single-stranded peptide nucleic acid oligonucleotide linked to a 7 aminoacid peptide 17\n",
      "16-base single-stranded PNA oligonucleotide linked to a 7-aminoacid peptide 18\n",
      "177Lu-tetraxetan-tetulomab 21\n",
      "1-deoxygalactonojirimycin hydrochloride 25\n",
      "(1R, 2R)-Octanoic acid [2-(2’,3’-dihydro-benzo [1,4] dioxin-6’-yl)-2-hydroxy-1-pyrrolidin-1-ylmethyl-ethyl]-amide-L-tartaric acid salt 28\n",
      "(1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol 29\n",
      "(1R,3R,4R,5S)-3-O-[2-O-benzoyl-3-O-(sodium(2S)-3-cyclohexyl-propanoate-2-yl)-ß-D-galactopyranosyl]-4-O-(a-L-fucopyranosyl)-5-orothylamido-cyclohexane-1-carboxylic acid ethyl-2-amidyl-ethyloxy-2-acetyl-(8-amino-1,3,6-naphthalene-tris sodium sulfonate) amide 30\n",
      "(1S,4R,5R,7S)-3,4-dibenzyl-2-oxo-6,8-dioxa-3-azabyciclo[3.2.1]octane-7-carboxylic acid-L-lysine 32\n",
      "20-pentaerythritol poly (oxy-1,2-ethanediyl)-carboxymethyl-glycinate-7-ethyl-10-hydroxycamptothecine 10-[1,4'-bipiperidine]-1'-carboxylate 33\n",
      "2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)-piperazin-1-yl)-8-methylimidazo[1,2-alpha]pyridin-3-yl)-(methyl)amino)-4-(4-fluorophenyl)-thiazole-5-carbonitrile 42\n",
      "2-(2-phenylvinyl)-4-[4-methylpiperazin-1-yl)]-6-(5-methyl-2H-pyrazol-3-yl-amino)-pyrimidine L(+) tartrate salt 44\n",
      "((2-aminoethyl) carbamic acid (2R,5S,8S,11S,14R,17S,19aS)-11-(4-aminobutyl)-5-benzyl-8-(4-benzyloxy benzyl)-14-(1H-indol-3-ylmethyl)-4,7,10,13,16,19-hexaoxo-17-phenyloctadecahydro-3a,6,9,12,15,18-hexaazacyclopentacyclooctadecen-2-yl ester, di[(S)-2-aminosuccinic acid] salt 53\n",
      "2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide 54\n",
      "2-hydroxypropyl-ß-cyclodextrin 60\n",
      "2'-O-(2-methoxyethyl)phosphorothioate antisense oligonucleotide targeting the growth hormone receptor 65\n",
      "2'-O-methyl phosphorothioate RNA oligonucleotide, 5'-m5CUGm5CUGm5CUGm5CUGm5CUGm5CUGm5CUG-3' 66\n",
      "(-)-(2R)-3-(2-hydroxymethylindanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate 67\n",
      "(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl) amino)methyl)tetrahydrofuran-3,4-diol 68\n",
      "(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl) amino)methyl)tetrahydrofuran-3,4-diol 69\n",
      "(2R,3S)-2-(4-cyclopentylaminophenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid(4-methyl-3-trifluoromethylphenyl)amide 70\n",
      "(2R,3S)-2-(4-cyclopentylaminophenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid(4-methyl-3-trifluoromethylphenyl)amide 71\n",
      "2S, 4R ketoconazole 72\n",
      "(2S)-2-[(4R)-2-oxo-4-propyltetrahydro-1H-pyrrol-1-yl] butanamide 76\n",
      "3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt 79\n",
      "3-(4'aminoisoindoline-1'-one)-1-piperidine-2,6-dione 80\n",
      "3-(4'aminoisoindoline-1'-one)-1-piperidine-2,6-dione 81\n",
      "(3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid 83\n",
      "(3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazole-3-yl]-benzoic acid 84\n",
      "3-methoxy-pregnenolone 89\n",
      "4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine x HCl 105\n",
      "4,6,4’–trimethylangelicin 108\n",
      "4-amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride 113\n",
      "[4-aminobutanoic acid-glycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-L-aspartyl](cyclo 1-Dgamma17) 114\n",
      "4-imino-1, 3-diazobicyclo-[3.1.0]-hexan-2-one 116\n",
      "505 amino acid protein, corresponding to amino acids 2-506 of the wild type human histidyl-tRNA synthetase 121\n",
      "5,10,15,20-tetrakis(2,6-difluoro-3-N-methylsulfamoylphenyl)bacteriochlorin 122\n",
      "[5,10,15,20-tetrakis(4-carboxyphenyl)-21H,23H-porphine]manganese(III) chloride 123\n",
      "5,5'-(4-(trifluromethyl)benzylazanediyl)bis(methylene)diquinolin-8-ol 127\n",
      "5'-ASCSASTSCSASGSTSCSTSGSASUSASASGSCSTSA-3' 131\n",
      "5-(ethylsulfonyl)-2-(naphthalen-2-yl)benzo[d]oxazole 136\n",
      "(5R,5aR,8aR,9S)-9-[[4,6-O-[(R)-Ethylidene]-(-D-glucopyranosyl]-oxy]-5-(4-({[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl}oxy)-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydroisobenzofuro[5,6-f][1,3]benzodioxol-6(5aH)-one 139\n",
      "5(S)-(2'-hydroxy ethoxy)-20(S)- camptothecin 140\n",
      "(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide 141\n",
      "68Ga-DOTA-pABzA-DIG-dPhe-Gln-Trp-Ala-Val-Gly-His-NHCH[(CH2-CH(CH3)2]2 143\n",
      "6alpha-ethyl-chenodeoxycholic acid 144\n",
      "(6aR, 10aR)-3-(1',1'-dimethylheptyl)-delta-8-tetrahydro-cannabinol-9-carboxylic acid 145\n",
      "(6aR,10aR)-3-(1',1'-dimethylheptyl)-delta-8-tetrahydrocannabinol-9-carboxylic acid 146\n",
      "(6aS)-1,10-dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,9-diol 147\n",
      "6-thioguanine (oral liquid) 153\n",
      "7-beta-hydroxycholesteryl-3-beta-oleate 154\n",
      "8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl-1,2,4-triazolo[3,4-f][1,6]naphthyridin-3(2H)-one mono-hydrochloride 155\n",
      "9-cis-Retinyl acetate 157\n",
      "A combination of H-Lys-Lys-Gly-Pro-Arg-Cys(SH)-Leu-Thr-Arg-Tyr-Tyr-Ser-Ser-Phe-Val-Asn-Met-Glu-Gly-Lys-Lys-OH and H-Lys-Lys-Gly-Asp-Asn-Ile-Met-Val-Thr-Phe-Arg-Asn-Gln-Ala-Ser-Arg-Pro-Tyr-Gly-Lys-Lys-OH 158\n",
      "A highly purified formulation of Staphylococcus aureus protein A 159\n",
      "A lentiviral vector pseudotyped by the Indiana serotype of the vesicular stomatitis virus G protein encoding an antigen derived from the Tax, HBZ, p12I and p30II HTLV-1 proteins 160\n",
      "A lentiviral vector pseudotyped by the New-Jersey serotype of the vesicular stomatitis virus G protein encoding an antigen derived from the Tax, HBZ, p12I and p30II HTLV-1 proteins 161\n",
      "A mixture of anti-CD3 mAb (SPV-T3a)-ricin A chain fusion protein and anti-CD7 mAb (WT1)-ricin A chain fusion protein 162\n",
      "A non-covalent trimer of tumour necrosis factor fused to an antibody specific to the extra-domain B of fibronectin in single-chain variable fragment format 163\n",
      "AASSGVSTPGSAGHDIITEQPRS 164\n",
      "Adeno-associated viral vector containing DNA encoding an RNAi targeting rhodopsin / adeno-associated viral vector containing a rhodopsin gene 174\n",
      "Adeno-associated viral vector containing modified U1 snRNA 175\n",
      "Adeno-associated viral vector containing porphobilinogen deaminase gene 176\n",
      "Adeno-associated viral vector containing the human alpha-N-acetylglucosaminidase gene 177\n",
      "Adeno-associated viral vector containing the human ARSB gene 178\n",
      "Adeno-associated viral vector containing the human factor IX gene 179\n",
      "Adeno-associated viral vector containing the human factor IX gene 180\n",
      "Adeno-associated viral vector containing the human NADH dehydrogenase 4 gene 181\n",
      "Adeno-associated viral vector expressing lipoprotein lipase 182\n",
      "Adeno-associated viral vector of serotype 5 containing the human alanine-glyoxylate aminotransferase gene 183\n",
      "Adeno-associated viral vector serotype 2/2 containing a gene encoding the channelrhodopsin-2 protein 184\n",
      "Adeno-associated viral vector serotype 2 containing the human CHM gene encoding human Rab escort protein 1 185\n",
      "Adeno-associated viral vector serotype 2 containing the human REP1 gene 186\n",
      "Adeno-associated viral vector serotype 2.7m8 containing the ChrimsonR-tdTomato gene 187\n",
      "Adeno-associated viral vector serotype 5 containing a B-domain deleted variant of human coagulation factor VIII gene 188\n",
      "Adeno-associated viral vector serotype 5 containing the human CHM gene 189\n",
      "Adeno-associated viral vector serotype 5 containing the human RLBP1 gene 190\n",
      "Adeno-associated viral vector serotype 8 containing the human CNGA3 gene under the control of a cone arrestin promoter 191\n",
      "Adeno-associated viral vector serotype 8 containing the human factor VII gene 192\n",
      "Adeno-associated viral vector serotype 8 containing the human glucose-6-phosphatase gene 193\n",
      "Adeno-associated viral vector serotype 8 containing the human GUCY2D gene 194\n",
      "Adeno-associated viral vector serotype 8 containing the human MD1 gene 195\n",
      "Adeno-associated viral vector serotype 8 containing the human MTM1 gene 196\n",
      "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene 197\n",
      "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene 198\n",
      "Adeno-associated viral vector serotype 8 containing the human UGT1A1 gene 199\n",
      "Adeno-associated viral vector serotype 8 encoding engineered rhodopsin DNA-binding repressor and human rhodopsin expression cassettes 200\n",
      "Adeno-associated viral vector serotype 8 encoding human ornithine transcarbamylase 201\n",
      "Adeno-associated viral vector serotype 8 encoding the human ATP7B gene under the control of the human alpha-1 antitrypsin promoter 202\n",
      "Adeno-associated viral vector serotype 9 containing the human cardiac calsequestrin gene 203\n",
      "Adeno-associated viral vector serotype 9 containing the human glucocerebrosidase gene 204\n",
      "Adeno-associated viral vector serotype 9 containing the human HGSNAT gene 205\n",
      "Adeno-associated viral vector serotype 9 containing the human iduronate-2-sulfatase gene 206\n",
      "Adeno-associated viral vector serotype 9 containing the human mini-dystrophin gene 207\n",
      "Adeno-associated viral vector serotype 9 containing the human N-acetylglucosaminidase alpha gene 208\n",
      "Adeno-associated viral vector serotype 9 containing the human SMN gene 209\n",
      "Adeno-associated viral vector serotype 9 containing the human sulfamidase gene 210\n",
      "Adeno-associated viral vector serotype rh.10 carrying the human N-sulfoglucosamine sulfohydrolase cDNA 211\n",
      "Adeno-associated viral vector serotype rh10 containing the human factor IX gene 212\n",
      "Adenoviral vector containing human p53 gene 213\n",
      "Adenoviral vector serotype 5 containing the vascular endothelial growth factor D isoform (preprocessed short form) from a CMV promoter 214\n",
      "Adenovirus associated viral vector serotype 2 containing the human RPE65 gene 215\n",
      "Adenovirus associated viral vector serotype 4 containing the human RPE65 gene 216\n",
      "Adenovirus associated viral vector serotype 4 containing the human RPE65 gene 217\n",
      "Adenovirus associated viral vector serotype 5 containing the human pde6ß gene 218\n",
      "Adenovirus associated viral vector serotype 5 containing the human RPE65 gene 219\n",
      "Adenovirus associated viral vector serotype 5 containing the human RPGR gene 220\n",
      "Adenovirus associated viral vector serotype 8 containing the human CNGB3 gene 221\n",
      "Adenovirus serotype 5 containing partial E1A deletion and an integrin-binding domain 222\n",
      "Adenovirus-associated vector containing human Fas-c gene 223\n",
      "Adenovirus-associated viral vector serotype 10 carrying the human N-sulfoglucosamine sulfohydrolase and sulfatase modifying factor 1 cDNAs 224\n",
      "Adenovirus-associated viral vector serotype 2 containing the human RPE65 gene 225\n",
      "Adenovirus-mediated Herpes simplex Virus-thymidine kinase gene 226\n",
      "Adenovirus-specific T-cells derived from allogeneic donor leukocytes, expanded ex vivo 227\n",
      "Adrenomedullin 228\n",
      "Adult human bone-marrow-derived, ex-vivo-expanded, pooled allogeneic mesenchymal stromal cells 229\n",
      "Alginate oligosaccharide (G-block) fragment 233\n",
      "Allogeneic adipose-derived adult mesenchymal stem cells contained in a fibrin-based bioengineered dermis 236\n",
      "Allogeneic and autologous haptenised and irradiated cells and cell lysates derived from glioma 237\n",
      "Allogeneic aortic endothelial cells cultured in a porcine gelatin matrix 238\n",
      "Allogeneic bone marrow derived mesenchymal cells expanded ex vivo in synthetic media 239\n",
      "Allogeneic bone marrow derived mesenchymal cells expanded ex vivo in synthetic media 240\n",
      "Allogeneic bone-marrow derived ex-vivo expanded multipotent adult progenitor cells 241\n",
      "Allogeneic CD34+ cells expanded ex vivo with an aryl hydrocarbon receptor antagonist 242\n",
      "Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of the viral antigens of cytomegalovirus, adenovirus and Epstein-Barr virus 243\n",
      "Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of the viral antigens of cytomegalovirus, adenovirus and Epstein-Barr virus 244\n",
      "Allogeneic CD4+ and CD8+ T lymphocytes ex vivo incubated with synthetic peptides of the viral antigens of cytomegalovirus, adenovirus and Epstein-Barr virus 245\n",
      "Allogeneic cytomegalovirus-specific cytotoxic T lymphocytes 246\n",
      "Allogeneic donor-derived ex-vivo expanded T lymphocytes transduced with a retroviral vector containing inducible caspase 9 and truncated CD19 247\n",
      "Allogeneic Epstein-Barr virus specific cytotoxic T lymphocytes 248\n",
      "Allogeneic ex vivo-generated natural killer cells from CD34+ umbilical cord blood progenitor cells 249\n",
      "Allogeneic ex-vivo-expanded human umbilical cord blood-derived mesenchymal stem cells 250\n",
      "Allogeneic fetal human retinal progenitor cells expanded ex vivo 251\n",
      "Allogeneic human adult stem cells, isolated from skeletal muscle and expanded ex vivo 252\n",
      "Allogeneic human dendritic cells derived from a CD34+ progenitor cell line 253\n",
      "Allogeneic human dermal fibroblasts 254\n",
      "Allogeneic motor neuron progenitor cells derived from human embryonic stem cells 255\n",
      "Allogeneic motor neuron progenitor cells derived from human embryonic stem cells 256\n",
      "Allogeneic peripheral blood mononuclear cells incubated ex vivo with 16, 16-dimethyl prostaglandin E2 and dexamethasone 257\n",
      "Allogeneic peripheral blood mononuclear cells induced to an early apoptotic state 258\n",
      "Allogeneic T cells encoding an exogenous TK gene 259\n",
      "Allogeneic T cells encoding an exogenous TK gene 260\n",
      "Allogeneic, umbilical cord blood-derived, ex vivo-expanded, haematopoietic CD133+ cells / allogeneic, umbilical cord blood-derived, non-expanded, haematopoietic CD133- cells 261\n",
      "Alpha-1 antitrypsin (inhalation use) 264\n",
      "Alpha-1 antitrypsin (inhalation use) 265\n",
      "Alpha-1 proteinase inhibitor 266\n",
      "Alpha-1 proteinase inhibitor (for inhalation use) 267\n",
      "Alpha-1 proteinase inhibitor (inhalation use) 268\n",
      "Alpha-1 proteinase inhibitor (inhalation use) 269\n",
      "Alpha-tocotrienol quinone 271\n",
      "Amikacin sulfate (liposomal) 278\n",
      "Ammonium tetrathiomolybdate 279\n",
      "Amphotericin B (for inhalation use) 280\n",
      "Anti epidermal growth factor receptor antibody h-R3 281\n",
      "Anti-epithelial cell adhesion molecule / anti-CD3 monoclonal antibody 282\n",
      "Anti-H5N1 equine immunoglobulin F(ab')2 fragments 283\n",
      "Antisense NF-Kß p65 Oligonucleotide 284\n",
      "Antisense oligonucleotide 5'-d[P-Thio](CCCTG CTCCC CCCTG GCTCC)-3' 285\n",
      "Antisense oligonucleotide complementary to the exonic splicer enhancer sequence at intron 26 of the centrosomal protein 290 pre-mRNA 286\n",
      "Antisense oligonucleotide directed against TGF-beta2 mRNA 287\n",
      "Antisense oligonucleotide targeted to the SMN2 gene 288\n",
      "Antisense oligonucleotide targeting the F508delta mutation of CFTR 289\n",
      "Antisense Oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT) 290\n",
      "Antisense Oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT) 291\n",
      "Antisense Oligonucleotide (TATCCGGAGGGCTCGCCATGCTGCT) 292\n",
      "Apomorphine hydrochloride (inhalation use) 296\n",
      "Autologous adipose tissue-derived stromal vascular fraction cells 313\n",
      "Autologous bone marrow-derived mesenchymal stromal cells secreting neurotrophic factors 314\n",
      "Autologous bone marrow-derived mononuclear cell fraction 315\n",
      "Autologous CD34+ cells transduced with a lentiviral vector containing the human ADA gene 316\n",
      "Autologous CD34+ cells transduced with a lentiviral vector containing the human RAG1 gene 317\n",
      "Autologous CD34+ cells transduced with a lentiviral vector containing the human SGSH gene 318\n",
      "Autologous CD34+ cells transduced with a lentiviral vector containing the human Wiskott-Aldrich syndrome gene 319\n",
      "Autologous CD34+ cells transduced with lentiviral vector encoding the human beta globin gene 320\n",
      "Autologous CD34+ cells transfected with lentiviral vector containing the human arylsulfatase A cDNA 321\n",
      "Autologous CD34+ cells transfected with lentiviral vector containing the Wiskott-Aldrich syndrome protein gene 322\n",
      "Autologous CD34+ cells transfected with retroviral vector containing adenosine deaminase gene 323\n",
      "Autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human beta A-T87Q-globin gene 324\n",
      "Autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human betaA-T87Q-globin gene 325\n",
      "Autologous CD4+ and CD8+ T-cells transduced with lentiviral vector containing an affinity-enhanced T-cell receptor targeting the New York esophageal antigen-1 326\n",
      "Autologous collagen type II-specific regulatory T cells 327\n",
      "Autologous dendritic cells incubated ex vivo with zebularine and factor VIII 328\n",
      "Autologous dendritic cells pulsed with allogeneic tumour cell lysate 329\n",
      "Autologous dendritic cells pulsed with autologous tumour cell lysate 330\n",
      "Autologous dendritic cells pulsed with recombinant human-fusion protein (mucin 1 - glutathione S transferase) coupled to oxidised polymannose 331\n",
      "Autologous dendritic cells pulsed with RNA from glioma stem cells 332\n",
      "Autologous dendritic cells pulsed with tumour antigen-derived synthetic peptides (MAGE-1, HER-2, AIM-2, TRP-2, gp-100, and interleukin-13 receptor alpha) 333\n",
      "Autologous dermal fibroblasts genetically modified ex vivo with a lentiviral vector containing the human COL7A1 gene 334\n",
      "Autologous Epstein-Barr virus specific T-cells derived from peripheral blood mononuclear cells, expanded ex vivo 335\n",
      "Autologous Epstein-Barr virus specific T-cells derived from peripheral blood mononuclear cells, expanded ex vivo 336\n",
      "Autologous ex-vivo-expanded leucocytes treated with 5-aza-2’-deoxycytidine 337\n",
      "Autologous haematopoietic cells genetically modified with a lentiviral vector containing the human gp91(phox) gene 338\n",
      "Autologous haematopoietic stem cells transduced with lentiviral vector encoding the human beta-globin gene 339\n",
      "Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA 340\n",
      "Autologous human peripheral blood Vdelta1+ T lymphocytes activated in vitro by cytokine and monoclonal antibody treatment 341\n",
      "Autologous mesenchymal stromal cells on a decellularised tracheal scaffold from a cadaveric donor 342\n",
      "Autologous mononuclear cells derived from human cord blood 343\n",
      "Autologous mononuclear cells derived from human cord blood 344\n",
      "Autologous regulatory T cells with an immunophenotype of CD4+CD25hiFoxP3+ 345\n",
      "Autologous renal cell tumor vaccine 346\n",
      "Autologous stromal vascular cell fraction from adipose tissue 347\n",
      "Autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19 348\n",
      "Autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19 349\n",
      "Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3 zeta chimeric antigen receptor 350\n",
      "Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor 351\n",
      "Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor 352\n",
      "Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor 353\n",
      "Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor 354\n",
      "Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor 355\n",
      "Autologous Tumor-Derived gp96 Heat Shock Protein-Peptide Complex 356\n",
      "Autologous tumor-derived immunoglobulin idiotype coupled to keyhole limpet haemocyanin 357\n",
      "Autologous tumor-derived immunoglobulin idiotype coupled to keyhole limpet haemocyanin 358\n",
      "Autologous tumour-derived gp96 heat shock protein-peptide complex 359\n",
      "Avian polyclonal IgY antibody against Pseudomonas aeruginosa 361\n",
      "Aztreonam lysinate (inhalation use) 366\n",
      "Bacterial lipase 367\n",
      "Beclomethasone 17, 21-dipropionate (oral use) 370\n",
      "Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl] 376\n",
      "Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl] 377\n",
      "Beta-artemether / lumefantrine (powder for oral suspension) 380\n",
      "Betaine anhydrous 381\n",
      "Bilayer engineered collagen hydrogel-based skin graft composed of autologous keratinocytes and fibroblasts 383\n",
      "Bilayer engineered skin composed of keratinocytes from the patient (autologous) and fibroblasts from a donor (allogeneic) embedded in a plasma matrix 384\n",
      "Biotinylated anti-tenascin monoclonal antibody for use with 90-Yttrium 386\n",
      "Bovine bile extract 389\n",
      "Budesonide (oral use) 397\n",
      "Cabiralizumab 398\n",
      "Carboxy pyrrolidine hexanoyl pyrrolidine carboxylate 407\n",
      "Cardiotrophin-1 409\n",
      "Cardiotrophin-1 410\n",
      "CD33-directed antibody-drug conjugate consisting of an antibody conjugated to a DNA cross-linking pyrrolobenzodiazepine dimer drug 416\n",
      "Chemically modified human recombinant sulfamidase 421\n",
      "Chimeric 2'-O-(2-methoxyethyl) modified oligonucleotide targeted to huntingtin RNA 423\n",
      "Chimeric fusion protein of recombinant human alpha-N-acetylglucosaminidase and human insulin-like growth factor 2 424\n",
      "Chimeric group B adenovirus (11p/3) with deletions in the E3 and E4 regions 425\n",
      "Chimeric IgG monoclonal antibody cG250 426\n",
      "Chimeric locked nucleic acid-deoxynucleoside phosphorothioate-linked oligonucleotide directed against microRNA-451 427\n",
      "Chimeric monoclonal antibody against claudin 6 428\n",
      "Chimeric monoclonal antibody against claudin-18 splice variant 2 429\n",
      "Chimeric monoclonal antibody against claudin-18 splice variant 2 430\n",
      "Chimeric monoclonal antibody against GD2 431\n",
      "Chimeric monoclonal antibody against GD2 432\n",
      "Chimeric monoclonal antibody to O-acetyl-GD2 antigen 433\n",
      "Chimeric monoclonal antibody to shiga-toxin 1 and 2 434\n",
      "Chimeric-anti-interleukin-6 monoclonal antibody 435\n",
      "Choline tetrathiomolybdate 441\n",
      "Ciclosporin (eye drops, solution) 446\n",
      "Ciclosporin (inhalation use) 447\n",
      "Ciclosporin (inhalation use) 448\n",
      "Ciprofloxacin (inhalation use) 449\n",
      "Ciprofloxacin (liposomal) 450\n",
      "Cisplatin (liposomal) 452\n",
      "Combination of 4-hydroxyandrostenedione, Serenoa serrulata fruit extract and alpha lipoic acid 456\n",
      "Copper meso-5,15-bis[3-[(1,2-dicarba-closo-dodecaboranyl)methoxy]phenyl]-meso-10,20-dinitroporphyrin 458\n",
      "Covalently closed DNA plasmids coding for cytomegalovirus phosphoprotein 65 and glycoprotein B genes 459\n",
      "Cultured allogeneic corneal limbal stem cells 462\n",
      "Cyclo-Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-Ala-Lys-Pro-Trp-Tyr-Cys 465\n",
      "Cyclo(-gamma-aminobutyryl-L-phenylalanyl-L-tryptophanyl-D-tryptophanyl-L-lysyl-L-threonyl-L phenylalanyl-N-3-carboxypropyl)-glycine amide, acetate salt 466\n",
      "Cyclo[L-alanyl-L-seryl-L-isoleucyl-L-prolyl-L-prolyl-L-glutaminyl-L-lysyl-L-tyrosyl-D-prolyl-L-prolyl-(2S)-2-aminodecanoyl-L-alpha-glutamyl-L-threonyl] acetate salt 467\n",
      "Cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinolin-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide, (L)-malate salt 468\n",
      "Daunorubicin (liposomal) 481\n",
      "Delta-9-tetrahydrocannabinol and cannabidiol from extracts of the Cannabis sativa L. plant 488\n",
      "Dexamethasone sodium phosphate encapsulated in human autologous erythrocytes 491\n",
      "Dexamethasone sodium phosphate encapsulated in human erythrocytes 492\n",
      "Diaspirin cross-linked haemoglobin 494\n",
      "Diaspirin cross-linked haemoglobin 495\n",
      "Dipalmitoylphosphatidylcholine, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol, sodium salt, synthetic surfactant protein C analogue and synthetic surfactant protein B analogue 501\n",
      "DNA plasmid encoding a recombinant fusion protein consisting of the extracellular domain of human TNFa p55 receptor linked to the human IgG1 Fc domain 502\n",
      "Donor lymphocyte preparation depleted of functional alloreactive T-cells 503\n",
      "Donor T lymphocytes depleted ex vivo of host alloreactive T cells using photodynamic treatment 504\n",
      "Donor T lymphocytes depleted ex vivo of host alloreactive T cells using photodynamic treatment 505\n",
      "Doxorubicin (administered after synthetic double-stranded siRNA oligonucleotide directed against claudin-5 complexed with polyethyleneimine) 507\n",
      "Doxorubicin hydrochloride (drug eluting beads) 508\n",
      "Doxorubicin hydrochloride in a lipid-based pegylated nanoparticle modified with a 31-aminoacid peptide targeting nucleolin 509\n",
      "Doxorubicin hydrochloride (in heat-sensitive liposomes) 510\n",
      "Doxorubicin hydrochloride (liposomal) 511\n",
      "Doxorubicin polyisohexylcyanoacrylate nanoparticles 512\n",
      "Doxorubicin(6-maleimidocaproyl)hydrazone 513\n",
      "Drotrecogin alfa (activated) 516\n",
      "Dry extract from birch bark (DER 0.1-0.2:1), extraction solvent n-heptane 95% (V/V) 517\n",
      "Duramycin 518\n",
      "E. Coli heat-shock protein 70 with bovine retinal S-antigen 519\n",
      "((E)-1-(4'-chlorophenyl)-3-(4-hydroxy-3-metoxyphenyl)prop-2-en-1-one) 520\n",
      "(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone 521\n",
      "Ecothiopate iodide 526\n",
      "Eflornithine in combination with sulindac 539\n",
      "Encapsulated human retinal pigment epithelial cell line transfected with plasmid vector expressing human ciliary neurotrophic factor 543\n",
      "Encapsulated human retinal pigment epithelial cell line transfected with plasmid vector expressing human ciliary neurotrophic factor 544\n",
      "Entolimod 547\n",
      "Eptacog alfa (activated) 550\n",
      "Estradiol Hemihydrate and Progesterone 553\n",
      "Ethyl Eicosopentaenoate 554\n",
      "Etilefrin 555\n",
      "Exendin (9-39) 558\n",
      "Exon 44 specific phosphorothioate oligonucleotide 560\n",
      "Exon 45 specific phosphorothioate oligonucleotide 561\n",
      "Exon 51 specific phosphorothioate oligonucleotide 562\n",
      "Exon 52 specific phosphorothioate oligonucleotide 563\n",
      "Exon 53 specific phosphorothioate oligonucleotide 564\n",
      "Exon 55 specific phosphorothioate oligonucleotide 565\n",
      "Expanded human allogeneic mesenchymal adult stem cells extracted from adipose tissue 566\n",
      "Expanded human allogeneic neural retinal progenitor cells extracted from neural retina 567\n",
      "Extract of Sorghum bicolour leaf, Pterocarpus osun stem, Piper guineense seed and Caryophylli flower 568\n",
      "Ex-vivo cultured adult human mesenchymal stem cells 569\n",
      "Ex-vivo expanded autologous human corneal epithelium containing stem cells 570\n",
      "Ex-vivo expanded autologous human corneal epithelium containing stem cells 571\n",
      "Ex-vivo-cultured human mesenchymal stromal cells 572\n",
      "Ex-vivo-expanded autologous fibroblasts transduced with lentiviral vector containing the COL7A1 gene 573\n",
      "Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a COL17A1-encoding retroviral vector 574\n",
      "Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a COL7A1-encoding retroviral vector 575\n",
      "Ex-vivo-expanded autologous human keratinocytes containing epidermal stem cells transduced with a LAMB3-encoding retroviral vector 576\n",
      "Fc- and CDR-modified humanised monoclonal antibody against C5 577\n",
      "Fibrinogen-coated albumin spheres 581\n",
      "Fibrinogen-coated albumin spheres 582\n",
      "Fimaporfin 585\n",
      "Fixed-dose combination of fosfomycin disodium and tobramycin 586\n",
      "Fixed-dose combination of (R-S) baclofen, naltrexone hydrochloride and D-sorbitol 587\n",
      "Florilglutamic acid (18F) 588\n",
      "Florilglutamic acid (18F) 589\n",
      "Fluciclovine (18F) 590\n",
      "Fluocinolone acetonide (prolonged-release intravitreal implant) 592\n",
      "Fusion proteins composed by a genetically modified cholera toxin subunit A1, peptides from the acetylcholine receptor alpha chain and a dimer of the D fragment from Staphylococcus aureus protein A 599\n",
      "G17(9) gastrin-diphtheria toxoid conjugate 600\n",
      "G17(9) gastrin-diphtheria toxoid conjugate 601\n",
      "Gadodiamide (liposomal) 602\n",
      "Gallium (68Ga)-edotreotide 603\n",
      "Gallium (68Ga)-pasireotide tetraxetan 604\n",
      "Gallium [Ga-68]-N-[(4,7,10-tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-Lcysteinyl-L-threonine-cyclic(2-7)disulfide 605\n",
      "Genetically modified adeno-associated viral vector serotype 9 expressing shRNA as well as a codon-optimized shRNA-insensitive wildtype PABPN1 607\n",
      "Genetically modified allogeneic (human) tumour cells for the expression of IL-7, GM-CSF, CD80 and CD154, in fixed combination with a DNA-based double stem loop immunomodulator (dSLIM) 608\n",
      "Genetically modified human adenovirus encoding human PH20 hyaluronidase 609\n",
      "Genetically modified Lactococcus lactis bacteria containing the human trefoil factor 1 gene 610\n",
      "Genetically modified serotype 5/3 adenovirus coding for granulocyte macrophage colony-stimulating factor 611\n",
      "Genetically modified serotype 5/3 adenovirus coding for granulocyte macrophage colony-stimulating factor 612\n",
      "Genetically modified serotype 5/3 adenovirus coding for granulocyte-macrophage colony-stimulating factor 613\n",
      "Genistein sodium salt dihydrate 614\n",
      "Glucopyranosyl lipid A stable emulsion and recombinant New York esophageal squamous cell carcinoma-1 protein 623\n",
      "[gly2] Recombinant human glucagon-like peptide 625\n",
      "Glyceryl tri-(4-phenylbutyrate) 626\n",
      "Glyceryl tri-(4-phenylbutyrate) 627\n",
      "Glyceryl tri-(4-phenylbutyrate) 628\n",
      "Glyceryl tri-(4-phenylbutyrate) 629\n",
      "Glyceryl tri-(4-phenylbutyrate) 630\n",
      "Glyceryl tri-(4-phenylbutyrate) 631\n",
      "Glyceryl tri-(4-phenylbutyrate) 632\n",
      "Glycosylation independent lysosomal targeting tagged recombinant human acid alpha glucosidase 633\n",
      "Glycyl-L-2-methylprolyl-L-glutamic acid 634\n",
      "Glycyl-L-2-methylprolyl-L-glutamic acid 635\n",
      "Granulocyte macrophage colony stimulating factor 636\n",
      "Haematopoietic stem cells modified with a lentiviral vector containing the CD18 gene 639\n",
      "H-Arg-Leu-Phe-Phe-Tyr-Arg-Lys-Ser-Val-OH, acetate salt & H-Tyr-Leu-Phe-Phe-Tyr-Arg-Lys-Ser-Val-OH, acetate salt 642\n",
      "H-D-Asp-D-Gln-D-Ser-D-Arg-D-Pro-D-Val-D-Gln-D-Pro-D-Phe-D-Leu-D-Asn-D-Leu-D-Thr-D-Thr-D-Pro-D-Arg-D-Lys-D-Pro-D-Arg-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-NH2 643\n",
      "Heat-killed Mycobacterium obuense (whole cell) 644\n",
      "Heat-killed Mycobacterium vaccae (whole cell) 645\n",
      "Heparin sodium 646\n",
      "Heparin-activated recombinant human fibroblast growth factor 1 (on a biodegradable device made from alpha-calcium sulphate hemihydrate) 647\n",
      "Heparin-binding epidermal growth factor-like growth factor (HB-EGF), amino acids 74-148 648\n",
      "Hepatitis C Immunoglobulin 649\n",
      "Herpes simplex 1 virus-thymidine kinase and truncated low affinity nerve growth factor receptor transfected donor lymphocytes 650\n",
      "Herpes simplex type 1 virus containing cellular B-myb gene as tumour-specific promoter 651\n",
      "Herpes simplex virus lacking infected cell protein 34.5 652\n",
      "Heterologous human adult liver derived stem cells 653\n",
      "Heterologous human adult liver derived stem cells 654\n",
      "Heterologous human adult liver-derived progenitor cells 655\n",
      "Heterologous human adult liver-derived progenitor cells 656\n",
      "Heterologous human adult liver-derived progenitor cells 657\n",
      "Heterologous human adult liver-derived progenitor cells 658\n",
      "Heterologous human adult liver-derived progenitor cells 659\n",
      "Heterologous human adult liver-derived progenitor cells 660\n",
      "Heterologous human adult liver-derived progenitor cells 661\n",
      "Heterologous human adult liver-derived stem cells 662\n",
      "Heterologous human adult liver-derived stem cells 663\n",
      "Heterologous human adult liver-derived stem cells 664\n",
      "HLA-B27 derived peptide (amino acid 125-138) 668\n",
      "H-Phe-Ser-Arg-Tyr-Ala-Arg-OH acetate 669\n",
      "Human allogeneic bone marrow derived osteoblastic-like cells 670\n",
      "Human allogeneic bone-marrow-derived osteoblastic cells 671\n",
      "Human Alpha1-Proteinase Inhibitor (respiratory use) 672\n",
      "Human anti-intercellular adhesion molecule\u001e",
      "1 monoclonal antibody 673\n",
      "Human apotransferrin 674\n",
      "Human autologous bone-forming cells derived from bone marrow stem cells 675\n",
      "Human autologous mesenchymal adult stem cells extracted from adipose tissue 676\n",
      "Human coagulation factor X 677\n",
      "Human cytomegalovirus immunoglobulin 678\n",
      "Human donor haematopoietic stem and progenitor cells that have been treated ex vivo with the protein transduction domain of the HIV-1 transactivation protein fused to MYC transcription factor 679\n",
      "Human embryonic stem-cell-derived retinal pigment epithelial cells 680\n",
      "Human erythrocytes encapsulating inositol hexaphosphate 681\n",
      "Human haptoglobin 682\n",
      "Human hemin 683\n",
      "Human hepatoma cell line HepaRG in bioartificial liver 684\n",
      "Human heterologous liver cells (for infusion) 685\n",
      "Human heterologous liver cells (for infusion) 686\n",
      "Human heterologous liver cells (for infusion) 687\n",
      "Human heterologous liver cells (for infusion) 688\n",
      "Human heterologous liver cells (for infusion) 689\n",
      "Human heterologous liver cells (for infusion) 690\n",
      "Human immunoglobulin G1 constant region - human ectodysplasin-A1 receptor-binding domain fusion protein 691\n",
      "Human Interleukin-2 (glycosylated tetrasaccharide, glycosylated trisaccharide and non-glycosylated) (inhalation use) 692\n",
      "Human MHC non-restricted cytotoxic T-cell line 693\n",
      "Human monoclonal antibody against activin A 694\n",
      "Human monoclonal antibody against CD4 695\n",
      "Human monoclonal antibody against Fas ligand 696\n",
      "Human monoclonal antibody against human interleukin 13 697\n",
      "Human monoclonal antibody against Pseudomonas aeruginosa IATS-O1 698\n",
      "Human monoclonal antibody against Pseudomonas aeruginosa serotype O11 699\n",
      "Human monoclonal antibody targeting Staphylococcus aureus alpha-toxin 700\n",
      "Human monoclonal IgG1 antibody against tissue factor pathway inhibitor 701\n",
      "Human/murine chimeric monoclonal antibody against endoglin 702\n",
      "Human papilloma virus type 16 E6/E7 synthetic long peptides 703\n",
      "Human plasma-derived alpha-1 proteinase inhibitor 704\n",
      "Human plasmin 705\n",
      "Human plasminogen 706\n",
      "Human plasminogen 707\n",
      "Human platelet antigen-1a immunoglobulin 708\n",
      "Human reovirus type 3 Dearing strain 709\n",
      "Human reovirus type 3 Dearing strain 710\n",
      "Human Staphylococcus aureus immunoglobulin 711\n",
      "Human telomerase reverse transcriptase peptide (611-626) 712\n",
      "Human tumour necrosis factor alfa-derived peptide Cys-Gly-Gln-Arg-Glu-Thr-Pro-Glu-Gly-Ala-Glu-Ala-Lys-Pro-Trp-Tyr-Cys 713\n",
      "Humanised anti-alpha ? beta 6 monoclonal antibody 714\n",
      "Humanised antibody fragment (Ep-CAM)-truncated Pseudomonas exotoxin A fusion protein 715\n",
      "Humanised anti-CD37 monoclonal antibody conjugated to maytansinoid DM1 716\n",
      "Humanised anti-folate receptor 1 monoclonal antibody conjugated to maytansinoid DM4 717\n",
      "Humanised anti-IL-6 receptor monoclonal antibody 718\n",
      "Humanised Fc engineered monoclonal antibody against CD19 719\n",
      "Humanised Fc engineered monoclonal antibody against CD19 720\n",
      "Humanised fusion protein consisting of extracellular domain of CD24 linked to IgG1 Fc domain 721\n",
      "Humanised IgG1 kappa antibody against serum amyloid A and AL amyloid 722\n",
      "Humanised IgG1 monoclonal antibody against human eotaxin-2 723\n",
      "Humanised IgG1 monoclonal antibody against human KIR3DL2 724\n",
      "Humanised IgG1 monoclonal antibody against the receptor-binding site of human placental growth factor 725\n",
      "Humanised IgG4 monoclonal antibody against extracellular tau 726\n",
      "Humanised IgG4 monoclonal antibody against total complement component 1, subcomponent s 727\n",
      "Humanised IgG4 monoclonal antibody to the human toll-like receptor type 2 728\n",
      "Humanised monoclonal antibody against CD38 729\n",
      "Humanised monoclonal antibody against myostatin 730\n",
      "Humanised monoclonal antibody against P-selectin 731\n",
      "Humanised monoclonal antibody of the IgG4 kappa isotype targeting CD47 732\n",
      "Humanised monoclonal antibody targeting interleukin-15 733\n",
      "Humanised monoclonal antibody to the folate receptor alpha 734\n",
      "Humanised monoclonal IgG4 antibody against tissue factor pathway inhibitor 735\n",
      "Humanised monoclonal modified IgG4 antibody with bispecific structure targeting factors IX, IXa, X and Xa 736\n",
      "Humanised recombinant IgG4 anti-human tau antibody 737\n",
      "Humanised recombinant monoclonal antibody against epidermal growth factor receptor conjugated to maleimidocaproyl monomethylauristatin F 738\n",
      "Humanised single chain monoclonal antibody against CD37 739\n",
      "Humanized Agonistic Anti-CD28 Monoclonal Antibody 740\n",
      "Hydrocinnamate-[Orn-Pro-dCha-Trp-Arg]acetate 741\n",
      "Hydrocortisone (modified release tablet) 742\n",
      "Hydrocortisone (modified release tablet) 743\n",
      "Hydrocortisone (modified release tablet) 744\n",
      "Hydroxy-propyl-beta-cyclodextrin 746\n",
      "IL-12-secreting dendritic cells, loaded with autologous tumour lysate 760\n",
      "Imetelstat sodium 762\n",
      "Immortalised human C3A hepatoblastoma cells 764\n",
      "Immunoglobulin G1, anti-(human tumour-associated calcium signal transducer 2)(human-Mus musculus monoclonal hRS7 heavy chain), disulfide with human-Mus musculus monoclonal hRS7 k-chain, dimer, hexakis(thioether) with (4S)-4-[[[[4-[[(2S)-2-(4-aminobutyl)-2-[[2-[2-[[26-[4-[[[[4-[(3-mercapto-2,5-dioxo-1-pyrrolidinyl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-3,6,9,12,15,18,21,24-octaoxahexacos-1-yl]amino]-2-oxoethoxy]acetyl]amino]-1-oxoethyl]amino]phenyl]methoxy]carbonyl]oxy]-4,11-diethyl-9-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione 765\n",
      "Interferon beta 772\n",
      "Interferon gamma 773\n",
      "Interferon gamma 774\n",
      "Iodine (131I) chlorotoxin 775\n",
      "Iodine (131I) iobenguane 776\n",
      "Irinotecan hydrochloride (drug eluting beads) 777\n",
      "Isofagomine tartrate 780\n",
      "l, 1'-[1,4-phenylenebis (methylene)]-bis-1,4,8,11- tetraazacyclotetradecane 785\n",
      "Lactobacillus acidophilus and Bifidobacterium bifidum 786\n",
      "Lactobacillus reuteri 787\n",
      "Lanreotide acetate 788\n",
      "L-asparaginase encapsulated in erythrocytes 789\n",
      "L-asparaginase encapsulated in erythrocytes 790\n",
      "L-asparaginase encapsulated in erythrocytes 791\n",
      "L-cysteine, L-leucyl-L-alpha-glutamyl-L-alpha-glutamyl-L-lysyl-L-lysylglycyl-L-asparaginyl-L-tyrosyl-L-valyl-L-valyl-L-threonyl-L-alpha-aspartyl-L-histidyl-S-[1-[(4-carboxycyclohexyl)methyl]-2,5-dioxo-3-pyrrolidinyl]-, complex with keyhole limpet haemocyanin 792\n",
      "Lentiviral vector carrying the Fanconi anaemia-A (FANCA) gene 798\n",
      "Lentiviral vector containing the human ABCA4 gene 799\n",
      "Lentiviral vector containing the human liver and erythroid pyruvate kinase (PKLR) gene 800\n",
      "Lentiviral vector containing the human MYO7A gene 801\n",
      "Levamisol hydrochloride 807\n",
      "Lipid-complexed cisplatin 809\n",
      "Lipopolysaccharide of Ochrobactrum intermedium 810\n",
      "Liposomal combination of cytarabine and daunorubicin 811\n",
      "Lithium citrate tetrahydrate (in reverse-micelle formulation) 813\n",
      "Live attenuated Listeria monocytogenes bioengineered with a chimeric human epidermal growth factor receptor 2 fused to a truncated form of the Lm protein listeriolysin O 814\n",
      "Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin 815\n",
      "Live attenuated Listeria monocytogenes delta actA/delta inlB strain expressing human mesothelin 816\n",
      "Live attenuated Listeria monocytogenes transfected with plasmids encoding the HPV-16E7 protein fused to a truncated fragment of the Lm protein listeriolysin O 817\n",
      "Live-attenuated non-replicative Pseudomonas aeruginosa strain expressing large T antigen of Merkel cell polyomavirus 818\n",
      "L-Lysine-N-acetyl-L-cysteinate 819\n",
      "Low molecular weight dextran sulfate 822\n",
      "Low molecular weight dextran sulfate 823\n",
      "L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser 824\n",
      "L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser 825\n",
      "L-threo-3,4-dihydroxyphenylserine 828\n",
      "Lutetium (177Lu) edotreotide 830\n",
      "Lutetium (177Lu)-N-[(4,7,10-Tricarboxymethyl-1,4,7,10-tetraazacyclododec-1-yl)acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophanyl-L-lysyl-L-threoninyl-L-cysteinyl-L-threonine-cyclic(2-7)disulfide 831\n",
      "Lutetium-177(3+),S2,S7-cyclo[N-{4,7,10-tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl}-4-chloro-L-phenylalanyl-D-cysteinyl-4-[(4S)-2,6-dioxo-1,3-diazinane-4-carboxamido]-L-phenylalanyl-4-(carbamoylamino)-D-phenylalanyl-L-lysyl-L-threonyl-L-cysteinyl-D-tyrosinamide] 832\n",
      "Macromolecular conjugate of heparin sodium on a polymer backbone 835\n",
      "(manganese, dichloro [(4aR, 13aR, 17aR, 21aR)-1, 2, 3, 4, 4a, 5, 6, 12, 13, 13a, 14, 15, 16, 17, 17a, 18, 19, 20, 21, 21°-eicosahydro-11, 7-nitrilo-7H-dibenzo[ b,h] [1,4,7,10] tetraazacycloheptadecine-?N5, ?N13, ?N18, ?N21, ?N22]-) 836\n",
      "Masitinib mesilate 841\n",
      "Masitinib mesilate 842\n",
      "Maytansinoid-conjugated human monoclonal antibody against mesothelin 844\n",
      "Mercaptopurine (oral liquid) 858\n",
      "Mercaptopurine (oral suspension) 859\n",
      "Metastable technetium 99 [99mTc] demogastrin 2 860\n",
      "Methotrexate (oral liquid) 863\n",
      "Methyl 3-((2R)-2-hydroxy-4-(((((S)-1-methoxy-1-oxopropan-2-yl) amino)(phenoxy)phosphoryl)oxy)-3,3-dimethylbutanamido)propanoate 865\n",
      "Methylthioninium 868\n",
      "Metreleptin 873\n",
      "Metreleptin 874\n",
      "Metreleptin 875\n",
      "Milciclib maleate 889\n",
      "Mixture of seven synthetic fragments consisting of p21 RAS peptides 893\n",
      "Mixture of two adeno-associated viral vectors of serotype 8 containing the 5'-half sequence of human ABCA4 gene and the 3'-half sequence of human ABCA4 gene 894\n",
      "Mixture of two adeno-associated viral vectors of serotype 8 containing the 5'-half sequence of human MYO7A gene and the 3'-half sequence of human MYO7A gene 895\n",
      "Mixture of two allogeneic human pancreatic cancer cell lines stably transduced with a retroviral vector encoding the murine alpha-(1,3)-galactosyltransferase gene 896\n",
      "Modified adenovirus serotype 5/35 containing a CMV promoter-driven transgene cassette with the human transgenes for a membrane-bound CD40 ligand and full length 4-1BBL 897\n",
      "Modified mRNA encoding the UGT1A1 protein 898\n",
      "Modified recombinant human C-type natriuretic peptide 899\n",
      "Monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E 903\n",
      "Monoclonal antibody against human CD30 covalently linked to the cytotoxin monomethylauristatin E 904\n",
      "Multilamellar microvesicle comprising phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, phosphatidylserine, phospatidylinositol and cholesterol 906\n",
      "Muramyl tripeptide phosphatidyl ethanolamine 907\n",
      "Murine anti-CD22 antibody variable region fused to truncated Pseudomonas exotoxin 38 908\n",
      "Murine IgM monoclonal antibody binding to alpha beta T-cell receptor 909\n",
      "Murine monoclonal antibody against CD26 910\n",
      "N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide 912\n",
      "N- (2-Amino-phenyl)-4-[(4-pyridin-3-yl-pyrimidin-2-ylamino)-methyl] benzamide 913\n",
      "N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide 914\n",
      "N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate 917\n",
      "N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl) amino] isonicotinamide hydrochloride 919\n",
      "N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide hydrochloride 920\n",
      "N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine to be used with folic acid 924\n",
      "N-(4-methoxyphenyl)-N,2,6-trimethylfuro[2,3-d]pyrimidin-4-amine 925\n",
      "Nanobody directed towards the human A1 domain of von Willebrand factor 936\n",
      "Nanoliposomal irinotecan 937\n",
      "N-Butyldeoxygalactonojirimycin 940\n",
      "N-({Carbamoylmethyl-[3-(2-oxo-pyrrolidin-1-yl)-propyl]-carbamoyl}-methyl)-2-[2-(2-fluoro-phenyl)-ethylamino]-N-isobutyl-acetamide 941\n",
      "N-(cyanomethyl)-4-(2-{[4-(morpholin-4-yl)phenyl]amino}pyrimidin-4-yl)benzamide, dihydrochloride salt 943\n",
      "NGR-human tumour necrosis factor 948\n",
      "NGR-human tumour necrosis factor 949\n",
      "NH2-Cys-Ser-Ser-Val-Thr-Ala-Trp-Thr-Thr-Gly-Cys-Gly-CONH2 950\n",
      "N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide 951\n",
      "N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide 952\n",
      "N-hydroxy-4-(3-methyl-2-(S)-phenyl-butyrylamino) benzamide 953\n",
      "Nimorazole maleate 957\n",
      "[Nle4, D-Phe7]-alpha-melanocyte stimulating hormone 967\n",
      "N-methyl D-(2,3,4,5,6-pentahydroxy-hexyl)-ammonium; 2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate 968\n",
      "N-methyl-4-({4-[({3-methyl(methylsulfonyl)aminopyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride 969\n",
      "N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole 972\n",
      "N-(methyl-diazacyclohexyl-methylbenzamide)-azaphenyl-aminothiopyrrole 973\n",
      "N,N'-bis(2-mercaptoethyl)isophthalamide 974\n",
      "N-terminal hexaglutamine-tagged recombinant human N-acetylgalactosamine-6-sulfate sulfatase 976\n",
      "N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate 977\n",
      "N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate 978\n",
      "N-tert-butyl-3-[(5-methyl-2-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl)amino] benzenesulfonamide dihydrochloride monohydrate 979\n",
      "Octenidine dihydrochloride 984\n",
      "Octreotide acetate (oral use) 985\n",
      "Octreotide chloride (lipid depot solution) 986\n",
      "Olaptesed pegol 989\n",
      "Oleylphosphocholine 991\n",
      "Ovine anti-colchicine polyclonal antibody fragments 998\n",
      "Ovine-specific immunoglobulin (Fab) fragments raised against Vipera berus venom 999\n",
      "Oxalobacter formigenes strain HC-1 1000\n",
      "Oxalobacter formigenes strain HC-1 1001\n",
      "Paclitaxel (aqueous gel) 1003\n",
      "Paclitaxel (liposomal) 1004\n",
      "Paclitaxel (micellar) 1005\n",
      "Paclitaxel-succinate-Arg-Arg-Leu-Ser-Tyr-Ser-Arg-Arg-Arg-Phe 1006\n",
      "Pancreatic enzymes (cross linked enzyme crystal lipase, protease, amylase) 1008\n",
      "Particles comprised of methacrylic acid based co-polymer, cross-linked with a bi-functional cross-linker, purified to bind L-phenylalanine and L-phenylalanine containing peptides 1013\n",
      "Pegylated arginine deiminase 1016\n",
      "Pegylated B-domain-deleted sequence-modified recombinant human factor VIII 1017\n",
      "Pegylated carboxyhaemoglobin 1018\n",
      "Pegylated L-asparaginase 1019\n",
      "Pegylated proline-interferon alpha-2b 1020\n",
      "Pegylated recombinant arginine deiminase 1021\n",
      "Pegylated recombinant Erwinia chrysanthemi L-asparaginase 1022\n",
      "Pegylated recombinant factor VIII 1023\n",
      "Pegylated recombinant human factor IX 1024\n",
      "Pegylated recombinant human hyaluronidase PH20 1025\n",
      "Pegylated recombinant human interleukin-10 1026\n",
      "Pegylated recombinant phenylalanine ammonia lyase 1027\n",
      "Pentosan polysulfate sodium 1029\n",
      "Pentosan polysulfate sodium 1030\n",
      "Pentosan polysulfate sodium 1031\n",
      "Pentosan polysulfate sodium 1032\n",
      "Peptide 144 TGF- ß1 inhibitor (TSLDASIIWAMMQN) 1033\n",
      "Peptide 144 TGF- ß1 inhibitor (TSLDASIIWAMMQN) 1034\n",
      "Peptides mimicking antigen receptors on autoimmune B cells and autoimmune T cells associated with myasthenia gravis 1035\n",
      "P-ethoxy growth factor receptor-bound protein 2 antisense oligonucleotide 1037\n",
      "Phenol, 4-[2-(aminomethyl)-4-thiazolyl]-2,6-bis(1,1-dimethylethyl)monohydrochloride 1038\n",
      "Phosphorothioate oligonucleotide targeted to apolipoprotein C-III 1040\n",
      "Phosphorothioate oligonucleotide targeted to transthyretin 1041\n",
      "Plasmid DNA encoding the human cystic fibrosis transmembrane conductance regulator gene complexed with a non-viral, cationic lipid based gene transfer agent 1045\n",
      "Polihexanide 1047\n",
      "Poloxamer 188 1048\n",
      "Poly[2-[(4-{[1-carboxy-2-(hexadecylcarbamoyl)ethyl]sulfanyl}-2,3-bis({2-[((2S)-2-(2-{[(2R)-2-carbamoyl-(2-{[(2S)-1-ethoxy-3-(3-hydroxy-4oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}ethyl]sulfanyl}-3-{[(2S)-1-ethoxy-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)-1-oxopropan-2-yl]carbamoyl}propanamido)-3-(3-hydroxy-4-oxo-1,4-dihydropyridin-1-yl)propanoyl Ethyl ester) )-methoxy]acetyl}oxy)butyl)sulfanyl]-3-(hexadecylcarbamoyl)propanoic acid]-poly(ethylene glycol)-ester] 1049\n",
      "Polyethylene glycol-modified human recombinant truncated cystathionine beta-synthase 1050\n",
      "Poly(oxy-1,2-ethanediyl), alpha-(carboxymethyl)-omega-methoxy-,amide with arginase 1 [cobalt cofactor] (synthetic human) (1:10), trimer 1051\n",
      "Pr-D-Cys-Met-Pip-Arg-Leu-Arg-Sar-Cys-Lys-Arg-Pro-Tyr-Tle-Leu-OH 1060\n",
      "Pro-Pro-Thr-Val-Pro-Thr-Arg 1062\n",
      "Purified bromelain 1063\n",
      "Pyr-His-Trp-Ser-Tyr-D-Lys(doxorubicinylglutarate)-Leu-Arg-Pro-Gly-NH2, acetate salt 1064\n",
      "Pyridoxalated haemoglobin polyoxyethylene 1066\n",
      "Pyridoxine and L-pyroglutamic acid 1067\n",
      "(R)-1-[1-(4-acetoxy-3,3-dimethyl-2-oxo-butyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-3-(3-methylamino-phenyl)-urea 1068\n",
      "R-azasetron besylate 1077\n",
      "R-baclofen 1078\n",
      "Recombinant adeno-associated viral vector containing human acid alfa-glucosidase-gene 1079\n",
      "Recombinant adeno-associated viral vector containing human alpha-1 antitrypsin gene 1080\n",
      "Recombinant adeno-associated viral vector containing human CNGA3 gene 1081\n",
      "Recombinant adeno-associated viral vector containing the human CNGB3 gene 1082\n",
      "Recombinant adeno-associated viral vector containing the human retinoschisin gene 1083\n",
      "Recombinant adeno-associated viral vector containing the human RPGR gene 1084\n",
      "Recombinant adeno-associated viral vector encoding a human micro-dystrophin gene under the control of a muscle specific promoter 1085\n",
      "Recombinant adeno-associated viral vector serotype 2 carrying the gene for the human aromatic L-amino acid decarboxylase protein 1086\n",
      "Recombinant adeno-associated viral vector serotype 9 carrying the gene for the human E6-AP ubiquitin protein ligase 1087\n",
      "Recombinant adeno-associated viral vector serotype 9 containing the human N-alpha-acetylglucosaminidase gene 1088\n",
      "Recombinant antibody construct against human CD30 and CD16A 1089\n",
      "Recombinant antibody derivative against human CD19 and CD3 1090\n",
      "Recombinant antibody derivative against human CD19 and CD3 1091\n",
      "Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein 1092\n",
      "Recombinant anti-CD3-bi-single-chain-Fv-diphtheria toxin fusion protein 1093\n",
      "Recombinant chimeric monoclonal antibody against CD20 1094\n",
      "Recombinant derivative of C3 transferase 1095\n",
      "Recombinant dog gastric lipase 1096\n",
      "Recombinant factor VIIa modified with three terminal repeats derived from the ß chain of human chorionic gonadotropin 1097\n",
      "Recombinant factor VIIa modified with three terminal repeats derived from the ß chain of human chorionic gonadotropin 1098\n",
      "Recombinant factor VIIa modified with three terminal repeats derived from the ß chain of human chorionic gonadotropin 1099\n",
      "Recombinant fusion protein consisting of a modified form of the extracellular domain of human activin receptor IIB linked to the human IgG1 Fc domain 1100\n",
      "Recombinant fusion protein consisting of a modified form of the extracellular domain of human activin receptor IIB linked to the human IgG1 Fc domain 1101\n",
      "Recombinant fusion protein consisting of human coagulation factor IX attached to the Fc domain of human IgG1 1102\n",
      "Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule 1103\n",
      "Recombinant fusion protein consisting of the extracellular portion of CD95 fused to the Fc part of a human IgG1 molecule 1104\n",
      "Recombinant fusion protein linking coagulation factor VIIa with albumin 1105\n",
      "Recombinant fusion protein linking human coagulation factor IX with human albumin 1106\n",
      "Recombinant fusion protein linking human coagulation factor VIIa with human albumin 1107\n",
      "Recombinant fusion protein linking human coagulation factor VIIa with human albumin 1108\n",
      "Recombinant fusion protein of circulary-permuted IL-4 and pseudomonas exotoxin A, [IL-4(38-37)-PE38KDEL] 1109\n",
      "Recombinant glycoprotein gp350 of Epstein-Barr virus 1110\n",
      "Recombinant histidine-tagged idiotype immunoglobulin Fab fragment of clonal B-cell receptors 1111\n",
      "Recombinant histidine-tagged idiotype immunoglobulin Fab fragment of clonal B-cell receptors 1112\n",
      "Recombinant histidine-tagged idiotype immunoglobulin Fab fragment of clonal B-cell receptors 1113\n",
      "Recombinant histidine-tagged idiotype immunoglobulin Fab fragment of clonal B-cell receptors 1114\n",
      "Recombinant human acid alpha-glucosidase conjugated with mannose-6-phosphate analogues 1115\n",
      "Recombinant human acid ceramidase 1116\n",
      "Recombinant human acid ceramidase 1117\n",
      "Recombinant human acid sphingomyelinase 1118\n",
      "Recombinant human ADAMTS-13 1119\n",
      "Recombinant human alkaline phosphatase 1120\n",
      "Recombinant human alpha 1 chain homotrimer of type VII collagen 1121\n",
      "Recombinant human alpha-1-microglobulin 1122\n",
      "Recombinant human alpha-glucosidase conjugated with multiple copies of synthetic bismannose-6-phosphate-tetra-mannose glycan 1123\n",
      "Recombinant human alpha-N-acetylglucosaminidase 1124\n",
      "Recombinant human anti-interferon gamma monoclonal antibody 1125\n",
      "Recombinant human apolipoprotein A-I in a complex with phospholipids 1126\n",
      "Recombinant human apolipoprotein A-I in a complex with phospholipids 1127\n",
      "Recombinant human arylsulfatase A 1128\n",
      "Recombinant human aspartylglucosaminidase 1129\n",
      "Recombinant human beta-glucuronidase 1130\n",
      "Recombinant human bone morphogenetic protein 4 1131\n",
      "Recombinant human C1-inhibitor 1132\n",
      "Recombinant human cerebral dopamine neurotrophic factor 1133\n",
      "Recombinant human club cell 10 KDa protein 1134\n",
      "Recombinant human CXCL8 mutant 1135\n",
      "Recombinant human CXCL8 mutant 1136\n",
      "Recombinant human diamine oxidase 1137\n",
      "Recombinant human dyskerin 1138\n",
      "Recombinant human elafin 1139\n",
      "Recombinant human galactocerebrosidase 1140\n",
      "Recombinant human glutamate oxaloacetate transaminase 1 1141\n",
      "Recombinant human growth hormone modified by fusion with two hydrophilic polypeptide chains 1142\n",
      "Recombinant human heat shock protein 70 1143\n",
      "Recombinant human heparan N-sulfatase 1144\n",
      "Recombinant human hepatitis C monoclonal antibody against C4 region of E1 1145\n",
      "Recombinant human hepatocarcinoma-intestine-pancreas / pancreatic associated protein 1146\n",
      "Recombinant human histone H1.3 and recombinant human N-bis-met-histone H1.3 1147\n",
      "Recombinant human histone H1.3 and recombinant human N-bis-met-histone H1.3 1148\n",
      "Recombinant human IgG1 kappa light chain monoclonal antibody targeting plasma kallikrein 1149\n",
      "Recombinant human insulin receptor monoclonal antibody-fused iduronate 2-sulfatase 1150\n",
      "Recombinant human insulin receptor monoclonal antibody-fused-a-L-iduronidase 1151\n",
      "Recombinant human interleukin-12 1152\n",
      "Recombinant human interleukin-3 truncated diphtheria toxin fusion protein 1153\n",
      "Recombinant human interleukin-3 truncated diphtheria toxin fusion protein 1154\n",
      "Recombinant human interleukin-7 1155\n",
      "Recombinant human lecithin cholesterol acyltransferase 1156\n",
      "Recombinant human lysosomal acid lipase 1157\n",
      "Recombinant human mesencephalic astrocyte-derived neurotrophic factor 1158\n",
      "Recombinant human methionine proinsulin 1159\n",
      "Recombinant human minibody against complement component C5 1160\n",
      "Recombinant human minibody against complement component C5 1161\n",
      "Recombinant Human minibody against complement component C5 fused with RGD-motif 1162\n",
      "Recombinant human monoclonal antibody against activin receptor type IIB 1163\n",
      "Recombinant human monoclonal antibody against hepatitis B virus 1164\n",
      "Recombinant human monoclonal antibody binding to vascular adhesion protein-1 1165\n",
      "Recombinant human monoclonal antibody of the IgG1 kappa class against human macrophage colony-stimulating factor 1166\n",
      "Recombinant human monoclonal antibody to human Nogo-A protein of the IgG4/kappa class 1167\n",
      "Recombinant human monoclonal antibody to insulin receptor 1168\n",
      "Recombinant human monoclonal IgG1 antibody against programmed death ligand-1 1169\n",
      "Recombinant human monoclonal IgG1 antibody for fibroblast growth factor 23 1170\n",
      "Recombinant human monoclonal IgM antibody targeting glucose-regulated protein 78 1171\n",
      "Recombinant human N-acetylgalactosamine-6-sulfatase 1172\n",
      "Recombinant human nerve growth factor 1173\n",
      "Recombinant human nerve growth factor 1174\n",
      "Recombinant human parathyroid hormone 1175\n",
      "Recombinant human pentraxin-2 1176\n",
      "Recombinant human pentraxin-2 1177\n",
      "Recombinant human pentraxin-2 1178\n",
      "Recombinant human pentraxin-2 1179\n",
      "Recombinant Human Porphobilinogen Deaminase 1180\n",
      "Recombinant human proinsulin 1181\n",
      "Recombinant human soluble Fc-gamma receptor Iib 1182\n",
      "Recombinant human surfactant protein D 1183\n",
      "Recombinant human tissue non-specific alkaline phosphatase - Fc - deca-aspartate fusion protein 1184\n",
      "Recombinant human transglutaminase 1 encapsulated into liposomes 1185\n",
      "Recombinant human tripeptidyl-peptidase 1 1186\n",
      "Recombinant human type I pancreatic elastase 1187\n",
      "Recombinant human vascular endothelial growth factor 1188\n",
      "Recombinant human von Willebrand factor 1189\n",
      "Recombinant human a-Mannosidase 1190\n",
      "Recombinant humanised anti-human interleukin-1 beta monoclonal antibody 1191\n",
      "Recombinant humanised monoclonal antibody against human complement component C5a 1192\n",
      "Recombinant humanised monoclonal IgG2 lambda antibody against human sclerostin 1193\n",
      "Recombinant IgG degrading enzyme of Streptococcus pyogenes 1194\n",
      "Recombinant kallikrein inhibitor 1195\n",
      "Recombinant megakaryopoeisis-stimulating protein 1196\n",
      "Recombinant modified human growth hormone 1197\n",
      "Recombinant modified vaccinia Ankara expressing human 5T4 1198\n",
      "Recombinant monoclonal antibody to human serum amyloid P component 1199\n",
      "Recombinant monoclonal IgG1 antibody against T-cell immune response cDNA 7 1200\n",
      "Recombinant protein consisting of modified human growth hormone releasing hormone and the translocation and endopeptidase domains of botulinum toxin serotype D 1201\n",
      "Recombinant protein derived from the saliva of the Ornithodoros moubata tick 1202\n",
      "Recombinant protein derived from the saliva of the Ornithodoros moubata tick 1203\n",
      "Recombinant P-selectin glycoprotein immunoglobulin 1204\n",
      "Recombinant self-complementary adeno-associated viral vector serotype 9 containing the human CLN3 gene 1205\n",
      "Recombinant thymidine phosphorylase encapsulated in autologous erythrocytes 1206\n",
      "Reduced oxydised N-acetyl heparin 1207\n",
      "Repertaxin L-lysine salt 1209\n",
      "Retroviral gamma-c cDNA containing vector 1214\n",
      "Ribonucleotide reductase R2 specific phosphorothioate oligonucleotide 1215\n",
      "RNA, [P-deoxy-P-(dimethylamino)] (2',3'-dideoxy-2',3'-imino-2',3'-seco) (2'a?5') (C-m5U-m5U-A-C-A-G-G-C-m5U-C-C-A-A-m5U-A-G-m5U-G-G-m5U-C-A-G-m5U), 5' [P-[4-[[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]carbonyl]-1-piperazinyl]-N,N-dimethylaminophosphonamidate], 3'\u001e",
      "[2'a-[N2-acetyl-L-arginyl-6-aminohexanoyl-L-arginyl-L-arginyl-ß-alanyl-L-arginyl-L-arginyl-6-aminohexanoyl-L-arginyl-L-arginyl-ß-alanyl-L-arginyl-6-aminohexanoyl-ß-alanyl], octahydrochloride 1224\n",
      "RNA, [P-deoxy-P-(dimethylamino)] (2',3'-dideoxy-2',3'-imino-2',3'-seco) (2'a?5')(C-m5U-C-C-A-A-C-A-m5U-C-A-A-G-G-A-A-G-A-m5U-G-G-C-A-m5U-m5U-m5U-C-m5U-A-G), P-[4-[[2-[2-(2-hydroxyethoxy)ethoxy] ethoxy]carbonyl]-1-piperazinyl]-N,N\u001e",
      "dimethylaminophosphonamidate 1225\n",
      "Rovalpituzumab tesirine 1226\n",
      "R-salbutamol sulphate 1227\n",
      "R,S-O-(3-piperidino-2-hydroxy-1-propyl)-nicotinic acid amidoxime dihydrochloride 1228\n",
      "S[+] apomorphine 1232\n",
      "(S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-O-[alpha-(2'', 4'', 5'', 7''-tetranitro-9''-fluorenylideneaminooxy)propionyl]-1H-pyrano[3', 4', 6', 7']indolizino[1,2-beta]-quinoline-3, 14-(4H), 12H)-dione, hydrochloride 1233\n",
      "(S)-2-(1-((6-amino-5-cyanopyrimidin-4-yl)amino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[2,1-f][1,2,4]triazine-5-carbonitrile 1234\n",
      "(S)-2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine 1236\n",
      "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide) 1240\n",
      "S3,S13-cyclo(D-tyrolsyl-L-isoleucyl-L-cysteinyl-L-valyl-1-methyl-L-tryptophyl-L-glutaminyl-L-aspartyl-L-tryptophyl-N-methyl-L-glycyl-L-alanyl-L-histidyl-L-arginyl-L-cysteinyl-N-methyl-L-isoleucinamide) 1241\n",
      "(S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride 1242\n",
      "S-acetyl-(S)-4'-phosphopantetheine, calcium salt 1245\n",
      "Sacrosidase 1246\n",
      "Self-complementary adeno-associated viral vector serotype 9 containing the SGSH gene 1251\n",
      "(S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate 1254\n",
      "Sevuparin sodium 1257\n",
      "Silibinin-C-2',3-dihydrogensuccinate, disodium salt 1260\n",
      "Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol and palmitic acid 1261\n",
      "Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol and palmitic acid 1262\n",
      "Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol and palmitic acid 1263\n",
      "Sinapultide, dipalmitoylphosphatidylcholine, palmitoyl-oleoyl phosphatidylglycerol, sodium salt and palmitic acid 1264\n",
      "Sindbis virus envelope pseudotyped lentiviral vector encoding New York esophageal squamous cell carcinoma-1 protein 1265\n",
      "Single-chain urokinase plasminogen activator 1266\n",
      "Skin equivalent graft genetically corrected with a COL7A1-encoding SIN retroviral vector 1274\n",
      "(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate 1276\n",
      "Sodium ascorbate and menadione sodium bisulfite 1282\n",
      "Sulfonated monophosphorylated mannose oligosaccharide 1311\n",
      "Synthetic 12 amino acids peptide designed after subcommissural organ spondin 1312\n",
      "Synthetic 15-amino-acid macrocyclic peptide acylated with a polyethyleneglycol palmitoylated linker 1313\n",
      "Synthetic 47-amino-acid N-myristoylated lipopeptide, derived from the preS region of hepatitis B virus 1314\n",
      "Synthetic double-stranded oligomer specific to the SERPINA1 gene and containing a cholesterol-conjugated, acyclic nucleobase analogue 1315\n",
      "Synthetic double-stranded RNA oligonucleotide specific to hydroxyacid oxidase 1 gene 1316\n",
      "Synthetic double-stranded short interfering RNA oligonucleotide directed against proopiomelanocortin 1317\n",
      "Synthetic double-stranded siRNA oligonucleotide directed against antithrombin mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues 1318\n",
      "Synthetic double-stranded siRNA oligonucleotide directed against antithrombin mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues 1319\n",
      "Synthetic double-stranded siRNA oligonucleotide directed against claudin-5 complexed with polyethyleneimine (prior to administration of doxorubicin) 1320\n",
      "Synthetic double-stranded siRNA oligonucleotide directed against delta-aminolevulinic acid synthase 1 mRNA covalently linked to a ligand containing three N-acetylgalactosamine residues 1321\n",
      "Synthetic double-stranded siRNA oligonucleotide directed against hydroxyacid oxidase 1 mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues 1322\n",
      "Synthetic double-stranded siRNA oligonucleotide directed against p53 mRNA 1323\n",
      "Synthetic double-stranded siRNA oligonucleotide directed against the keratin 6a N171K mutation 1324\n",
      "Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA 1325\n",
      "Synthetic double-stranded siRNA oligonucleotide directed against transthyretin mRNA and covalently linked to a ligand containing three N-acetylgalactosamine residues 1326\n",
      "Synthetic hepcidin 1327\n",
      "Synthetic human hepcidin 1328\n",
      "Synthetic hypericin 1329\n",
      "Synthetic peptide L-cysteine, L-cysteinylglycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-, cyclic (1.fwdarw.17)-disulfide 1330\n",
      "Synthetic peptide L-cysteine, L-cysteinylglycyl-L-glutaminyl-L-arginyl-L-.alpha.-glutamyl-L-threonyl-L-prolyl-L-.alpha.-glutamylglycyl-L-alanyl-L-.alpha.-glutamyl-L-alanyl-L-lysyl-L-prolyl-L-tryptophyl-L-tyrosyl-, cyclic (1.fwdarw.17)-disulfide 1331\n",
      "Synthetic ribonucleic acid oligonucleotide directed against superoxide dismutase 1 messenger ribonucleic acid 1332\n",
      "Synthetic signal peptide of human mucin-1 (amino acids 1-21) 1333\n",
      "Tadekinig alfa 1334\n",
      "Talactoferrinum alfa 1336\n",
      "TGF-beta2 specific phosphorothioate antisense oligodeoxynucleotide 1351\n",
      "Three chimeric human/murine monoclonal antibodies against the Ebola (Zaire) surface glycoprotein 1354\n",
      "Tobramycin (inhalation powder) 1359\n",
      "Topotecan hydrochloride (liposomal) 1362\n",
      "Trabedersen 1365\n",
      "Trans-4-[4-[5-[[6-(trifluoromethyl)-3-pyridinyl]amino]-2-pyridinyl]phenyl] cyclohexane acetic acid sodium salt 1367\n",
      "Trans-N1-((1R,2S)-2-phenylcyclopropyl)cyclohexane-1,4-diamine bis-hydrochloride 1368\n",
      "Treprostinil diethanolamine 1374\n",
      "Treprostinil diethanolamine (oral use) 1375\n",
      "Treprostinil sodium (inhalation use) 1377\n",
      "Trientine dihydrochloride 1380\n",
      "Two allogenic irradiated pancreatic tumour cell lines 1388\n",
      "Type I native bovine skin collagen 1389\n",
      "Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Gly-Gly-Asp-Leu-Leu-Pro-Arg-Gly-Ser 1390\n",
      "Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu, Ser-Gly-Gln-Ala-Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu-Pro-Ser-Cys-Leu-Glu-Ser, Arg-Ser-Asp-Glu-Leu-Val-Arg-His-His-Asn-Met-His-Gln-Arg-Asn-Met-Thr-Lys-Leu and Pro-Gly-Cys-Asn-Lys-Arg-Tyr-Phe-Lys-Leu-Ser-His-Leu-Gln-Met-His-Ser-Arg-Lys-His-Thr-Gly 1391\n",
      "Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu, Ser-Gly-Gln-Ala-Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu-Pro-Ser-Cys-Leu-Glu-Ser, Arg-Ser-Asp-Glu-Leu-Val-Arg-His-His-Asn-Met-His-Gln-Arg-Asn-Met-Thr-Lys-Leu and Pro-Gly-Cys-Asn-Lys-Arg-Tyr-Phe-Lys-Leu-Ser-His-Leu-Gln-Met-His-Ser-Arg-Lys-His-Thr-Gly 1392\n",
      "Ulinastatin 1396\n",
      "Vaccine consisting of 5 survivin peptides with different human leukocyte antigen restrictions 1398\n",
      "Vaccinia GM-CSF/TK-deactivated virus 1399\n",
      "Variant of recombinant human fibroblast growth factor 19 1403\n",
      "Vascular endothelial growth factor-D gene in an adenoviral vector for use with a collagen collar 1404\n",
      "Vasoactive Intestinal Peptide 1405\n",
      "Vector based on an adeno-associated virus serotype 2 backbone, pseudo-serotyped with a type 8 capsid, which carries the coding sequence of the human TYMP gene under the control of the human thyroxine binding globulin promoter 1406\n",
      "Vincristine sulphate liposomes 1414\n",
      "Viral vector containing DNA encoding the human SMN protein 1415\n",
      "Yttrium (90Y) edotreotide 1423\n",
      "Yttrium (90Y)-DOTA-radiolabelled humanized monoclonal antibody against mucin 1 1424\n",
      "Yttrium (90Y)-DTPA-radiolabelled chimeric monoclonal antibody against frizzled homologue 10 1425\n",
      "(Z)-3-(3-(3,5-bis(trifluoromethyl)phenyl)-1H-1,2,4-triazol-1-yl)-N'-(pyrazin-2-yl)acrylohydrazide 1426\n",
      "826 did not match\n",
      "6 combination drugs detected\n"
     ]
    }
   ],
   "source": [
    "drug_query = '''\n",
    "SELECT * WHERE {\n",
    "    ?compound wdt:P2275 ?who_name FILTER (LANG(?who_name) = \"en\") .  \n",
    "}\n",
    "'''\n",
    "\n",
    "# http://tinyurl.com/z6397rh\n",
    "drug_query = '''\n",
    "SELECT ?compound ?label ?who_name (GROUP_CONCAT(DISTINCT(?alias); separator=\"|\") AS ?aliases) WHERE {{\n",
    "  {{?compound wdt:P31 wd:Q11173 .}} UNION  # chemical compound\n",
    "  {{?compound wdt:P31 wd:Q12140 .}} UNION  # pharmaceutical drug\n",
    "  {{?compound wdt:P31 wd:Q79529 .}} UNION  # chemical substance\n",
    "  {{?compound wdt:P2275 ?who_name FILTER (LANG(?who_name) = \"en\") .}}\n",
    "  \n",
    "  OPTIONAL {{\n",
    "    ?compound rdfs:label ?label FILTER (LANG(?label) = \"en\") .\n",
    "  }}\n",
    "  OPTIONAL {{\n",
    "    ?compound skos:altLabel ?alias FILTER (LANG(?alias) = \"en\") .\n",
    "  }}\n",
    "}}\n",
    "GROUP BY ?compound ?label ?who_name ?aliases\n",
    "OFFSET {0}\n",
    "LIMIT 100000\n",
    "'''\n",
    "\n",
    "\n",
    "drug_qid_map = {}\n",
    "\n",
    "cc = 0\n",
    "while True:\n",
    "    r = wdi.wdi_core.WDItemEngine.execute_sparql_query(query=drug_query.format(100000 * cc))\n",
    "    cc += 1\n",
    "    \n",
    "    if len(r['results']['bindings']) == 0:\n",
    "        break\n",
    "    \n",
    "    for x in r['results']['bindings']:\n",
    "        qid = x['compound']['value']\n",
    "        \n",
    "        if 'who_name' in x:\n",
    "            drug_qid_map.update({x['who_name']['value'].lower(): qid})\n",
    "            \n",
    "        if 'label' in x:\n",
    "            drug_qid_map.update({x['label']['value'].lower(): qid})\n",
    "            \n",
    "        if 'aliases' in x:\n",
    "            drug_qid_map.update({y.lower(): qid for y in x['aliases']['value'].split('|')})\n",
    "            \n",
    "        count += 1\n",
    "            \n",
    "print('Drug to QID map has {} entries!'.format(len(drug_qid_map)))\n",
    "\n",
    "no_match_count = 0\n",
    "combo_drug_count = 0\n",
    "for count, line in eu_orphan_drugs.iterrows():\n",
    "#     print(count, line)\n",
    "    ema_name = line['Product']\n",
    "    if pd.notnull(line['inchi_key']):\n",
    "        continue\n",
    "    \n",
    "    if not all([y in drug_qid_map for y in ema_name.lower().split(' / ')]):\n",
    "        print(ema_name, count)\n",
    "        no_match_count += 1\n",
    "    \n",
    "    if ' / ' in ema_name:\n",
    "        combo_drug_count += 1 \n",
    "        \n",
    "print(no_match_count, 'did not match')\n",
    "print(combo_drug_count, 'combination drugs detected')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
